VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Jan 01, 2025 To Jan 17, 2025:


Bacillus anthracis (Anthrax)

  1. Avril A, Guillier S, Rasetti-Escargueil C. Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies Microorganisms 12(12) 2024 [PMID: 39770824]

Brucella (Brucellosis)

  1. Abbas F, Ali S, Muhammad A, Azam A, Moawad AA, Ejaz M, Iftikhar A, Dadar M. Human Brucellosis in the Rural and Urban Population of Pakistan: Seroprevalence, Risk Factors, and Clinical Manifestations Current microbiology 82(2):80 2025 [PMID: 39797980]
  2. Dadar M, Alamian S. In silico MLVA Analysis of Brucella melitensis from Human and Livestock in Iran Current microbiology 82(2):74 2025 [PMID: 39777506]
  3. Modise-Tlotleng BM, Mpoloka SW, Settypalli TBK, Hyera J, Kgotlele T, Kumile K, Sechele ME, Raboloko OO, Marobela-Raborokgwe C, Viljoen GJ, Cattoli G, Lamien CE. Molecular Testing of Zoonotic Bacteria in Cattle, Sheep, and Goat Abortion Cases in Botswana Microorganisms 12(12) 2024 [PMID: 39770846]
  4. Sibhat B, Adamu H, Asmare K, Lindahl JF, Magnusson U, Sisay Tessema T. Detection and Molecular Diversity of Brucella melitensis in Pastoral Livestock in North-Eastern Ethiopia Pathogens (Basel, Switzerland) 13(12) 2024 [PMID: 39770323]
  5. Izadi S, Moghaddas V, Feizi A, Bahreinipour A, Barati Z. Bovine brucellosis, associated risk factors and preventive measures in industrial cattle farms Heliyon 10(22):e40180 2024 [PMID: 39748974]

Burkholderia pseudomallei (Melioidosis)

  1. Tandhavanant S, Yimthin T, Sengyee S, Charoenwattanasatien R, Lebedev AA, Lafontaine ER, Hogan RJ, Chewapreecha C, West TE, Brett PJ, Burtnick MN, Chantratita N. Genetic variation of hemolysin co-regulated protein 1 affects the immunogenicity and pathogenicity of Burkholderia pseudomallei PLoS neglected tropical diseases 19(1):e0012758 2025 [PMID: 39761280]

Clostridium botulinum toxin (Botulism)

  1. Seiden B, Ajay D, Cheung F, Clements M, Pietzak E. Management of Lower Urinary Tract Symptoms during the Treatment for Non-Muscle Invasive Bladder Cancer Current urology reports 26(1):24 2025 [PMID: 39760811]
  2. Prygiel M, Mosiej E, Wdowiak K, Zasada AA. Passive Immunisation in the Treatment of Infectious Diseases Related to Highly Potent Bacterial Toxins Biomedicines 12(12) 2024 [PMID: 39767826]

Clostridium perfringens

  1. Du L, Jia S, Zhang W, Cai C, Liu Y, Wang C, Zhu Y, Ma X, Yang X, Wei Z, Xu K. Oral Yeast-Cell Microcapsule-Mediated DNA Vaccines Against Clostridium perfringens Induce Effective Intestinal Immunity and Modulate Gut Microbiota Vaccines 12(12) 2024 [PMID: 39772022]

Coronavirus

  1. Comparcini D, Cicolini G, Totaro M, Governatori L, Pastore F, Miniscalco D, Flacco ME, Cuscianna E, Tafuri S, Simonetti V. Influenza vaccination hesitancy and related factors among pregnant and breastfeeding women: A cross-sectional study Human vaccines & immunotherapeutics 21(1):2450858 2025 [PMID: 39809545]
  2. Qin C, Ding Y, Liu M, Liu J. Attitudes towards vaccination against COVID-19 during pregnancy and its determinants among people of reproductive age Human vaccines & immunotherapeutics 21(1):2450131 2025 [PMID: 39797690]
  3. Guan Y. The effectiveness of coercive measures in motivating vaccination: Evidence from China during the COVID-19 pandemic Global public health 20(1):2445827 2025 [PMID: 39773331]
  4. Parsons Leigh J, Moss SJ, MacDonald J, Cherak MS, Stelfox HT, Dubé È, Fiest KM, Halperin DM, Ahmed SB, MacDonald SE, Straus SE, Manca T, Ng Kamstra J, Soo A, Halperin SA. Considering the impact of vaccine communication in the COVID-19 pandemic among adults in Canada: A qualitative study of lessons learned for future vaccine campaigns Human vaccines & immunotherapeutics 21(1):2448052 2025 [PMID: 39773304]
  5. Liang X, Cai C, Yu FY, Ye D, Fang Y, Mo PKH, Wang Z. Changes in seasonal influenza vaccination uptake among older adults during and after the COVID-19 pandemic: Repeated random telephone surveys Human vaccines & immunotherapeutics 21(1):2449290 2025 [PMID: 39763233]
  6. Yao X, Lu WH, Qiao WT, Zhang YQ, Zhang BY, Li HX, Li JL. The highly pathogenic strain of porcine deltacoronavirus disrupts the intestinal barrier and causes diarrhea in newborn piglets Virulence 16(1):2446742 2025 [PMID: 39758030]
  7. Fritz AM, Smith AM. Poison, lies, war: A mixed methods content analysis of posts about COVID-19 vaccination on Gab Social Human vaccines & immunotherapeutics 21(1):2443999 2025 [PMID: 39749427]
  8. Saju AF, Mukundan A, Divyashree Ms, Chandrashekhar R, Mahadev Rao A. RNA diagnostics and therapeutics: a comprehensive review RNA biology 22(1):1-11 2025 [PMID: 39744758]
  9. Zhou S, Lai M, Tang S, Liu W, Shen M, Peng Z. Estimating cumulative infection rate of COVID-19 after adjusting the dynamic zero-COVID policy in China Infectious Disease Modelling 10(2):429-438 2025 [PMID: 39816753]
  10. Du S, Yang L, Chen X, Chen Y, Weng L, Huang H, Pang S. Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants Biochemical and biophysical research communications 746:151224 2025 [PMID: 39742790]
  11. Naghibosadat M, Babuadze GG, Pei Y, Hurst J, Salvant E, Gaete K, Biondi M, Moloo B, Goldstein A, Avery S, Ma K, Pietraszek A, Wootton SK, Alhaboub A, Martin B, Mubareka S, Corredor J, Sultana A, Adeekoa A, Budylowski P, Ostrowski M, Chao J, Nagy E, Kozak R. Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models Journal of virology :e0139024 2025 [PMID: 39817773]
  12. Jing S, Dai Z, Wu Y, Liu X, Zhang L, Liu X, Ren T, Fu J, Chen X, Wang W, Gu X, Ma L, Zhang S, Yu Y, Li L, Han Z, Su X, Qiao Y. Prevalence and influencing factors of occupational burnout among healthcare workers in the Chinese mainland during the late 2022 Omicron COVID-19 outbreak: a multicenter cross-sectional study BMC public health 25(1):171 2025 [PMID: 39815194]
  13. Beck MH, Brachaczek IA, Gebert P, Blohmer JU, Kaya AC, Zimmermann JSM, Radosa JC, Karsten MM. Incidence of seroma and postoperative complications after breast surgery before and during the Covid-19 pandemic: results from a retrospective multicenter analysis BMC cancer 25(1):91 2025 [PMID: 39815186]
  14. Chaddock NJM, Crossfield SSR, Pujades-Rodriguez M, Iles MM, Morgan AW. Genetic proxies for clinical traits are associated with increased risk of severe COVID-19 Scientific reports 15(1):2083 2025 [PMID: 39814935]
  15. Cheng C, Aruchunan E, Noor Aziz MH. Leveraging dynamics informed neural networks for predictive modeling of COVID-19 spread: a hybrid SEIRV-DNNs approach Scientific reports 15(1):2043 2025 [PMID: 39814760]
  16. Brugnoli E, Delmastro M. Dynamics and triggers of misinformation on vaccines PloS one 20(1):e0316258 2025 [PMID: 39813203]
  17. White CL, Richards KA, Huertas N Jr, Nayak JL, Sant AJ. Human HKU1-reactive CD4 T cells are enriched for cytolytic potential that persists in older adults The Journal of infectious diseases 2025 [PMID: 39812178]
  18. Chen AA, Renouf EM, Dean CB, Hu XJ. The effects of deprivation, age, and regional differences in COVID-19 mortality from 2020 to 2022: a retrospective analysis of public provincial data BMC public health 25(1):148 2025 [PMID: 39810147]
  19. Tuyishime A, Hahirwa I, Njunwa KJ, Nyiligira J. Benefits, challenges, and best practices of collaborative partnerships among health supply chain stakeholders in Rwanda: a cross-sectional study BMC health services research 25(1):75 2025 [PMID: 39810141]
  20. Penaloza L, Badiger S, Shetty AK. An Explorative Study on Knowledge, Attitudes, and Coronavirus Disease 2019 Vaccine Intention among Parents in India The American journal of tropical medicine and hygiene 2025 [PMID: 39808831]
  21. Taira K, Shiomi M, Nakabe T, Imanaka Y. The Association Between COVID-19 Vaccination Uptake and Information-Seeking Behaviors Using the Internet: Nationwide Cross-Sectional Study Journal of medical Internet research 27:e59352 2025 [PMID: 39808493]
  22. Therre M, Tokcan M, Markwirth P, Böhm M. [Vaccination and cardiovascular diseases] Herz 2025 [PMID: 39808306]
  23. Imamura T, Mochida K, Olukunmi B, Tchicondingosse L, Sapalalo P, Francisco KR, Aoki A, Ishiguro A, Takehara K. Evaluation of the impact of the state of emergency during the COVID-19 pandemic on childhood immunizations in Benguela Province, Angola Tropical medicine and health 53(1):5 2025 [PMID: 39806505]
  24. Faizal I, Chandra D, Tarwadi, Pambudi S, Nurhasanah A, Priambodo R, Yusuf M. Immunoinformatics-guided design of a multiepitope peptide vaccine targeting the receptor-binding domain of SARS-CoV-2 spike glycoprotein: insights from Indonesian samples Journal of integrative bioinformatics 2025 [PMID: 39801269]
  25. Shahhamzehei N, Abdelfatah S, Omer EA, Riedl M, Meesters C, Schwarzer-Sperber HS, Sutter K, Bringmann G, Schwarzer R, Efferth T. Diketopiperazine/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based library Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 183:117841 2025 [PMID: 39809126]
  26. Gopinathan U, Elgersma I, Dalsbø T, Bjørbæk M, Fretheim A. Strengthening research preparedness for crises: lessons from Norwegian government agencies in using randomized trials and quasi-experimental methods to evaluate public policy interventions Health research policy and systems 23(1):8 2025 [PMID: 39806454]
  27. Sumi A, Koyama M, Katagiri M, Ohtomo N. Spectral study of COVID-19 pandemic in Japan: The dependence of spectral gradient on the population size of the community PloS one 20(1):e0314233 2025 [PMID: 39804850]
  28. Chen Z, Feng L, Wang L, Zhang L, Zheng B, Fu H, Li F, Liu L, Lv Q, Deng R, Xu Y, Hu Y, Zheng J, Qin C, Bao L, Wang X, Jin Q. A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 Signal transduction and targeted therapy 10(1):14 2025 [PMID: 39800731]
  29. Shouman S, Hesham N, Salem TZ. Viruses and neurodegeneration: a growing concern Journal of translational medicine 23(1):46 2025 [PMID: 39800721]
  30. Li SN, Ni WT, Li R, Chen YW, Gao ZC. [Clinical characteristics of immunocompromised patients infected with COVID-19] Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 48(1):35-42 2025 [PMID: 39757094]
  31. Grimani A, Stoffel ST, von Wagner C, Sniehotta FF, Vlaev I. Using an inferior decoy alternative to nudge COVID-19 vaccination Scientific reports 15(1):1672 2025 [PMID: 39799148]
  32. Turbawaty DK, Komala DR, Andriyoko B. Insights into Omicron: Genomic Characterization and Inpatient Risk Assessment at Single Tertiary Hospital in Indonesia Journal of multidisciplinary healthcare 18:71-81 2025 [PMID: 39816439]
  33. Marques MS, Silva TPRD, Faria APV, Santos NCP, Souza JFA, Silva MA, Pereira PF, Matozinhos FP. Micro and macropolitical determinants for non-vaccination against COVID-19 in pregnant women in Belo Horizonte Revista brasileira de enfermagem 77Suppl 1(Suppl 1):e20230235 2025 [PMID: 39813426]
  34. Katic BJ, Katragkou A, Alvitres JL, Gurumurthy M, Li C, Schwab JV, Hasan UN, Gaur S, Weller AS, Kennedy MC, DiPentima C, Rohan C, Richlin B, Chu D, Otero I, Patel A, Thomas P, Friedman SM. Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence and Associated Risk Factors in a Large Cohort of US Children Open forum infectious diseases 12(1):ofae680 2025 [PMID: 39802208]
  35. Hamdan M, Kulabaş N, Küçükgüzel İ. In silico Evaluation of H1-Antihistamine as Potential Inhibitors of SARS-CoV-2 RNA-dependent RNA Polymerase: Repurposing Study of COVID-19 Therapy Turkish journal of pharmaceutical sciences 21(6):566-576 2025 [PMID: 39801109]
  36. Pickering H, Schaenman J, Phan HV, Maguire C, Tsitsiklis A, Rouphael N, Higuita NIA, Atkinson MA, Brakenridge S, Fung M, Messer W, Salehi-Rad R, Altman MC, Becker PM, Bosinger SE, Eckalbar W, Hoch A, Doni Jayavelu N, Kim-Schulze S, Jenkins M, Kleinstein SH, Krammer F, Maecker HT, Ozonoff A, Diray-Arce J, Shaw A, Baden L, Levy O, Reed EF, Langelier CR. Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients Nature communications 16(1):586 2025 [PMID: 39794319]
  37. Badillo-Sánchez N, Gómez-Salgado J, Allande-Cussó R, Yildirim M, López-López D, Goniewicz K, Prieto-Callejero B, Fagundo-Rivera J. Impact of the COVID-19 pandemic on the mental health of Nursing students: A systematic review and meta-analysis Medicine 104(2):e40797 2025 [PMID: 39792714]
  38. Lakshmipriya T, Gopinath SCB, Chen Y, Sasidharan S, Subramaniam S, Gunny AAN, Md Ali UF, Salimi MN, Fakhri MA, Salim ET, Thirugnanasambandan T. Current Scenario in Associating Clinical COVID-19 Biomarkers for Developing Surveillance Platforms Current medicinal chemistry 2025 [PMID: 39806951]
  39. Gastesi I, Domínguez-Rodríguez S, Le Prevost M, Ramírez A, Giaquinto C, Mesa ML, Ballesteros A, Jackson C, Vásquez-Hoyos P, Alvarez Moreno C, Grasa C, Epalza C, Soriano-Arandes A, Moraleda C, Tagarro A. Comorbidities Associated With Different Degrees of Severity in Children and Young People Hospitalized With Acute COVID-19 The Pediatric infectious disease journal 2025 [PMID: 39792633]
  40. Zhao F, Cong X, Huang X, Zheng Y, Zhao Q, Wen Y, Wu R, Du S, Cao S, Cong F, Wang Y. Interplay of swine acute diarrhoea syndrome coronavirus and the host intrinsic and innate immunity Veterinary research 56(1):5 2025 [PMID: 39789633]
  41. Pavoncello V, Kislaya I, Andrianarimanana DK, Marchese V, Rakotomalala R, Rasamoelina T, Veilleux S, Guth A, Zafinimampera AOT, Ratefiarisoa S, Totofotsy O, Doumbia CO, Rakotonavalona R, Ramananjanahary H, Randriamanantany ZA, May J, Rakotoarivelo RA, Puradiredja DI, Fusco D. Optimizing vaccine uptake in sub-Saharan Africa: a collaborative COVID-19 vaccination campaign in Madagascar using an adaptive approach Implementation science : IS 20(1):2 2025 [PMID: 39789551]
  42. Tanbakuchi D, Razavizadeh NT, Salari M, Farkhani EM, Shakeri MT, Tabatabaee SS, Raesi R, Ghavami V. Investigating the effectiveness of whole-virus, protein-based, and vector-based SARS-CoV-2 vaccines on the rates of COVID-19 infection, hospitalization, and mortality: a historical cohort study in Iran BMC infectious diseases 25(1):44 2025 [PMID: 39789435]
  43. Khalid K, Ahmad F, Anwar A, Ong SK. A Bibliometric Analysis on Multi-epitope Vaccine Development Against SARS-CoV-2: Current Status, Development, and Future Directions Molecular biotechnology 2025 [PMID: 39789401]
  44. Suntronwong N, Kanokudom S, Duangchinda T, Chantima W, Pakchotanon P, Klinfueng S, Puenpa J, Thatsanathorn T, Wanlapakorn N, Poovorawan Y. Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections Scientific reports 15(1):1454 2025 [PMID: 39789099]
  45. Ward D, Pattarapreeyakul L, Pitaksalee R, Thawong N, Sawaengdee W, Tuntigumthon S, Patterson C, Tetteh K, Campino S, Dhepakson P, Mahasirimongkol S, Clark TG. Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand Scientific reports 15(1):1519 2025 [PMID: 39789037]
  46. Guerrero-Araya E, Ravello C, Rosemblatt M, Perez-Acle T. Socioeconomic status correlates with COVID-19 vaccination coverage among primary and secondary students in the most populated city of Chile Scientific reports 15(1):1509 2025 [PMID: 39789033]
  47. Katz A, Ekuma O, Enns JE, Cavett T, Singer A, Sanchez-Ramirez DC, Keynan Y, Lix L, Walld R, Yogendran M, Nickel NC, Urquia M, Star L, Olafson K, Logsetty S, Spiwak R, Waruk J, Matharaarachichi S. Identifying people with post-COVID condition using linked, population-based administrative health data from Manitoba, Canada: prevalence and predictors in a cohort of COVID-positive individuals BMJ open 15(1):e087920 2025 [PMID: 39788761]
  48. Ahmad SI, Aliyu H, Usman R, Abubakar A, Maijawa MA, Suleiman BA, Balogun MS, Olorukooba A, Umeokonkwo CD, Maiyaki A, Abubakar MS, Abba AA, Yisa M, Zubair I, Onu CH, Jatau TD, Garba F, Kabir S. Factors influencing COVID-19 vaccine acceptability among household heads in northern Nigeria: a community-based cross-sectional study BMJ open 15(1):e083470 2025 [PMID: 39788760]
  49. Baker JM, Nakayama JY, O'Hegarty M, McGowan A, Teran RA, Bart SM, Sosa LE, Brockmeyer J, English K, Mosack K, Bhattacharyya S, Khubbar M, Yerkes NR, Campos B, Paegle A, McGee J, Herrera R, Pearlowitz M, Williams TW, Kirking HL, Tate JE. Household transmission of SARS-CoV-2 in five US jurisdictions: Comparison of Delta and Omicron variants PloS one 20(1):e0313680 2025 [PMID: 39787187]
  50. Suarez-Lledo V, Ortega-Martin E, Carretero-Bravo J, Ramos-Fiol B, Alvarez-Galvez J. Unraveling the Use of Disinformation Hashtags by Social Bots During the COVID-19 Pandemic: Social Networks Analysis JMIR infodemiology 5:e50021 2025 [PMID: 39786891]
  51. Magalhães BAP, Medeiros Minasi J, Lobato RC, Lemos LC, de Britto LS, Barros RM, de Martínez AMB, da Hora VP. Globally approved vaccines for COVID-19: a systematic review Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 2025 [PMID: 39786643]
  52. Mahneva O, Fakhoury TR, Hanspal SS, Gonzalez Velazquez JO, Patel N, Henzlova MJ. Systematic Review of COVID-19 and COVID-19 mRNA Vaccine Myocarditis in Athletes: Incidence, Diagnosis, Prognosis, and Return-to-Play Principles Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 2025 [PMID: 39784904]
  53. Igarashi Y, Tateishi S, Matsuoka J, Sawajima T, Kawasumi M, Harada A, Mori K. COVID-19 workplace countermeasures that occupational physicians could not change in Japan: a qualitative study BMC public health 25(1):93 2025 [PMID: 39780108]
  54. Dai ZX, Lan HJ, Hai N, Wang JY, Wang HH. Balancing fairness and efficiency in dynamic vaccine allocation during major infectious disease outbreaks Scientific reports 15(1):1371 2025 [PMID: 39779729]
  55. Yennamalli RM, Onteru SK. Immunoinformatics: A Veritable Toolbox for Livestock Omics and Veterinomics Omics : a journal of integrative biology 2025 [PMID: 39778891]
  56. Feldstein LR, Ruffin J, Wiegand RE, Borkowf CB, James-Gist J, Babu TM, Briggs-Hagen M, Chappell J, Chu HY, Englund JA, Kuntz JL, Lauring AS, Lo N, Carone M, Lockwood C, Martin ET, Midgley CM, Monto AS, Naleway AL, Ogilvie T, Saydah S, Schmidt MA, Schmitz JE, Smith N, Sohn I, Starita L, Talbot HK, Weil AA, Grijalva CG. Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States The Journal of infectious diseases 2025 [PMID: 39774936]
  57. Zhou X, Wu Y, Zhu Z, Lu C, Zhang C, Zeng L, Xie F, Zhang L, Zhou F. Mucosal immune response in biology, disease prevention and treatment Signal transduction and targeted therapy 10(1):7 2025 [PMID: 39774607]
  58. Everest L, Henderson J, Ma C, Prebeg M, Relihan J, Hawke LD. Relationship between mental health and substance abuse on COVID-19 vaccine hesitancy in youth: A mixed methods longitudinal cohort study PloS one 20(1):e0313157 2025 [PMID: 39774518]
  59. Phillips G, Racine E, Naughton AM, Lane J, Kearney PM. Understanding uptake of the COVID-19 vaccination among the homeless: A mixed methods evaluation PloS one 20(1):e0312617 2025 [PMID: 39774402]
  60. Bratcher A, Jones JM, Meyer WA 3rd, Waheed R, Yazgi H, Harris A, Gundlapalli AV, Clarke KEN. Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022 PloS one 20(1):e0313620 2025 [PMID: 39774376]
  61. Pethő Á, Dobi D, Kardos M, Schnabel K. Unexpected renal side effects of mRNA COVID-19 vaccines; a single-center experience and short review The American journal of the medical sciences 2025 [PMID: 39788422]
  62. Chutarong W, Thammalikhit R, Kraiklang R, Sawangwong A, Saechang O, Guo Y, Zhang W. Impact of digital device utilization on public health surveillance to enhance city resilience during the public health emergency response: A case study of SARS-CoV-2 response in Thailand (2020-2023) Digital health 11:20552076241304070 2025 [PMID: 39777061]
  63. Young DG, Rogers CS, Mayefsky I, Neufeld T, Niesen A, Reich PJ, Kao CM, Srinivasan M. Lessons Learned from a Quality Improvement Initiative to Increase COVID-19 Vaccination in Hospitalized Children Pediatric quality & safety 10(1):e782 2025 [PMID: 39776950]
  64. Xu Y, Tan Y, Peng Z, Liu M, Zhang B, Wei K. Advancing Myocarditis Research: Evaluating Animal Models for Enhanced Pathophysiological Insights Current cardiology reports 27(1):6 2025 [PMID: 39775161]
  65. Halfmann PJ, Patel RS, Loeffler K, Yasuhara A, Van De Velde LA, Yang JE, Chervin J, Troxell C, Huang M, Zheng N, Wright ER, Thomas PG, Wilson PC, Kawaoka Y, Kane RS. Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice Nature communications 16(1):462 2025 [PMID: 39774966]
  66. Pongsumpun P, Pongsumpun P, Tang IM, Lamwong J. The role of a vaccine booster for a fractional order model of the dynamic of COVID-19: a case study in Thailand Scientific reports 15(1):1162 2025 [PMID: 39774616]
  67. Hergott M, Andreski M, Rovers J. Vaccine hesitancy among health paraprofessionals: A mixed methods study PloS one 20(1):e0312708 2025 [PMID: 39774431]
  68. Mand N, Pecks U, Hutten M, Maier RF, Rüdiger M. Influence of SARS-CoV-2 variants of concern and maternal vaccination status on neonatal outcome BMJ paediatrics open 9(1) 2025 [PMID: 39773976]
  69. Jameel R, Greenfield S, Lavis A. A thematic analysis of UK COVID-19 vaccine hesitancy discussions on Twitter BMC public health 25(1):61 2025 [PMID: 39773610]
  70. McFadden K, Valkanas H, Rourke L, Li P, Bayoumi I. Innovations that helped with accessing and delivering primary care for infants and young children during COVID-19 BMC primary care 26(1):5 2025 [PMID: 39773347]
  71. Hu H, Leng C, Shu Y, Peng L, Wu F, Liu J, Zhang X, Zhou W, Xiao Q, Li Y, Wu B, Shen J, Li J, Gong R, Yan B, Deng F, Hu Z, Cao S, Wang M. Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2 Journal of virology :e0130724 2025 [PMID: 39772622]
  72. Maryewski XA, Krasilnikov MS, Straková P, Holoubek J, Frčková T, Panina IS, Krylov NA, Gvozdev DA, Denisov VS, Semenov AN, Lotosh NY, Selishcheva AA, Chistov AA, Gulyak EL, Kozhemyakin GL, Korshun VA, Efremov RG, Ustinov AV, Růžek D, Eyer L, Alferova VA. Membrane-Active Singlet Oxygen Photogenerators as a Paradigm for Broad-Spectrum Antivirals: The Case of Halogenated (BOron)-DIPYrromethenes ACS applied materials & interfaces 2025 [PMID: 39772406]
  73. van Rest A, Clarke A, Gounder P, Nie PK, Das C, Bush C, Rubin Z. COVID-19 outbreaks in nursing homes in Los Angeles County, March 2020-April 2022 Infection control and hospital epidemiology :1-7 2025 [PMID: 39763242]
  74. Mazigi O, Langley DB, Henry JY, Burnett DL, Sobti M, Walker GJ, Rouet R, Balachandran H, Lenthall H, Jackson J, Ubiparipovic S, Schofield P, Brown SHJ, Schulz SR, Hoffmann M, Pöhlmann S, Post J, Martinello M, Ahlenstiel G, Kelleher A, Rawlinson WD, Turville SG, Bull RA, Stewart AG, Jäck HM, Goodnow CC, Christ D. Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies Proceedings of the National Academy of Sciences of the United States of America 122(1):e2417544121 2025 [PMID: 39746041]
  75. Hodge AT, Tognolini AR, Martin EK, Eley VA. A cost analysis of the anaesthetic management of patients with confirmed or suspected coronavirus disease 2019 (COVID-19) in a tertiary referral hospital in Queensland, Australia Anaesthesia and intensive care :310057X241272108 2025 [PMID: 39757841]
  76. Yao Y, Yang Y, Wu Q, Liu M, Bao W, Wang Q, Cheng M, Chen Y, Yu Y, Cai Y, Zhang M, Yao J, He H, Jin C, Zheng C, Jin T, Tong D. Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough European journal of medical research 30(1):7 2025 [PMID: 39757187]
  77. Duan Y, Suo L, Li X, Bai C, Xu M, Wu J, Xu Z, Wang Q, Jiang B, Jiang M, Cao Y, Sun Y, Yang W, Li J, Feng L. Association between underlying conditions, multimorbidity, and COVID-19 vaccination status of adults aged ≥80 years old in Beijing, China Vaccine 47:126677 2025 [PMID: 39756213]
  78. Kulaç O, Toy AÖ, Kabak KE. Analysis of inoculation strategies during COVID-19 pandemic with an agent-based simulation approach Computers in biology and medicine 186:109564 2025 [PMID: 39754889]
  79. Guharay S. A data-driven approach to study temporal characteristics of COVID-19 infection and death Time Series for twelve countries across six continents BMC medical research methodology 25(1):1 2025 [PMID: 39754044]
  80. Abdel-Qader DH, Abdel-Qader H, Silverthorne J, Kongkaew C, Al Nimrawi M, Al Meslamani AZ, Obeidat NM, Hayajneh W, Hawari F, Arabi SZ, AbuRuz S. Investigating the point prevalence, types, severity, causes and predictors of vaccines administration errors during COVID-19 pandemic in Jordan PloS one 20(1):e0312050 2025 [PMID: 39752371]
  81. Casto AM, Paredes MI, Bennett JC, Luiten KG, Han PD, Gamboa LS, McDermot E, Gottlieb GS, Acker Z, Lo NK, McDonald D, McCaffrey KM, Figgins MD, Lockwood CM, Shendure J, Uyeki TM, Starita LM, Bedford T, Chu HY, Weil AA. SARS-CoV-2 Diversity and Transmission on a University Campus across Two Academic Years during the Pandemic Clinical chemistry 71(1):192-202 2025 [PMID: 39749508]
  82. Cohen J. Learning from a pandemic many are forgetting Science (New York, N.Y.) 387(6729):10-11 2025 [PMID: 39745964]
  83. Slatton BC, Cambrice FG, Omowale SS. COVID-19 Vaccine Hesitancy Among Black Women in the US JAMA network open 8(1):e2453511 2025 [PMID: 39786776]
  84. Wu HH, Chou WH, Lai HW, Su CH, Chien LJ, Tseng SH, Chang SC. Lessons from COVID-19 in Taiwan's long-term care facilities: A narrative review Journal of the Formosan Medical Association = Taiwan yi zhi 2025 [PMID: 39753419]
  85. Cui S, Han Q, Zhang R, Zeng S, Shao Y, Li Y, Li M, Liu W, Zheng J, Wang H. Integration of metabolomics methodologies for the development of predictive models for mortality risk in elderly patients with severe COVID-19 BMC infectious diseases 25(1):10 2025 [PMID: 39748307]
  86. Naffeti B, Ounissi Z, Srivastav AK, Stollenwerk N, Van-Dierdonck JB, Aguiar M. Modeling COVID-19 dynamics in the Basque Country: characterizing population immunity profile from 2020 to 2022 BMC infectious diseases 25(1):9 2025 [PMID: 39748283]
  87. Liu H, Zask A, Forouhar F, Iketani S, Williams A, Vaz DR, Habashi D, Choi K, Resnick SJ, Hong SJ, Lovett DH, Bai T, Chavez A, Ho DD, Stockwell BR. Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening Nature communications 16(1):152 2025 [PMID: 39747827]
  88. Zhang D, Chen C, Xie Y, Zhou S, Li D, Zeng F, Huang S, Lv Y, Huang X, Mao F, Kuang J, Gan J, Xu X, Chen S, Chen R, Zhang X, Xu S, Zeng M, Ren H, Bai F. Prevalence and risk factors of long COVID-19 persisting for 2 years in Hainan Province: a population-based prospective study Scientific reports 15(1):369 2025 [PMID: 39747631]
  89. Shukla K, Odedra KN, Jadeja BA. Exploring phytochemical, antioxidant, and antimicrobial properties of Plumeria pudica Jacq. leaves Scientific reports 15(1):193 2025 [PMID: 39747423]
  90. Skrami E, Faragalli A, Iommi M, Morbidoni M, Mancini C, Guidi A, Cardone A, Pompili M, Serafini P, Appignanesi R, Ferrante L, Carle F. Healthcare workers safety: a cohort study using healthcare utilisation databases on vaccination and vaccine timeliness impact against SARS-CoV-2 infection Scientific reports 15(1):162 2025 [PMID: 39747281]
  91. Huhn A, Nissley D, Wilson DB, Kutuzov MA, Donat R, Tan TK, Zhang Y, Barton MI, Liu C, Dejnirattisai W, Supasa P, Mongkolsapaya J, Townsend A, James W, Screaton G, van der Merwe PA, Deane CM, Isaacson SA, Dushek O. The molecular reach of antibodies crucially underpins their viral neutralisation capacity Nature communications 16(1):338 2025 [PMID: 39746910]
  92. Fachiroh J, Lestari SK, Paramita DK, Bintoro BS, Dewi FST, Lazuardi L, Rusadi CP, Sagenah EN, Arguni E. Seroconversion and dynamics of IgG anti-SARS-CoV-2 antibodies during the pandemic: A two-month observation cohort study on the population of Sleman in Indonesia PloS one 20(1):e0316360 2025 [PMID: 39746050]
  93. Trivedi A, Kushwaha T, Ishani, Vrati S, Gupta D, Kayampeta SR, Parvez MK, Inampudi KK, Appaiahgari MB, Sehgal D. Psoralidin acts as a dual protease inhibitor against PL(pro) and M(pro) of SARS-CoV-2 The FEBS journal 2025 [PMID: 39745898]
  94. Barrese M, Marzan MB, Hui L. Association Between COVID-19 Pandemic Phases and the Risk of Maternal Intensive Care Unit Admission: A Retrospective Analysis of 215,363 Victorian Hospital Admissions The Australian & New Zealand journal of obstetrics & gynaecology 2025 [PMID: 39745102]
  95. Li R, Hu JC, Rong L, He Y, Wang X, Lin X, Li W, Wu Y, Kuwentrai C, Su C, Yau T, Hung IF, Gao X, Huang JD. The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct immune responses against pathogen to target solid tumors Cell discovery 10(1):127 2025 [PMID: 39743545]
  96. Chua HK, Singh A, Wang Y, Goh YS, Chan CEZ, Chavatte JM, Lin RVTP, Su YCF, Ajelli M, Chia PY, Ong SWX, Lye DC, Young BE, Ejima K. Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection Protocol Journal of medical virology 97(1):e70174 2025 [PMID: 39817600]
  97. Arévalo-Herrera M, Rincón-Orozco B, González-Escobar JM, Herrera-Arévalo SM, Carrasquilla-Agudelo E, Serna-Ortega PA, Quiceno-García S, Palacio-Muñoz N, Rosero-López B, Mondol-Miranda E, Freyle-Roman I, Mendoza-Landinez B, Mora-Guevara E, Santos-Barbosa JC, Bohórquez-Martínez F, Bolaños-Cristancho N, Jiménez-Serna M, Nieto-Rojas MA, Suarez-Zamora D, Quintero-Espinosa J, Londoño-Trujillo D, Herrera-Valencia S. Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia Journal of medical virology 97(1):e70133 2025 [PMID: 39817585]
  98. Kalyoncu S, Sayili D, Kuyucu AZ, Soyturk H, Gullu S, Ersayan B, Tarman IO, Avci ME, Mert O, Haskok U, Tekin E, Akinturk H, Orkut R, Demirtas A, Tilmensagir I, Ulker C, Gungor B, Inan M. Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris Microbial biotechnology 18(1):e70077 2025 [PMID: 39815667]
  99. Sánchez-Simarro Á, Cuevas-Ferrando E, Fernández-Soto D, Grau B, Albert E, Giménez E, Avilés-Alía AI, Rusu L, Geller R, Reyburn HT, Navarro D. Estimating SARS-CoV-2 Omicron XBB.1.5 Spike-Directed Functional Antibody Levels From an Anti-Receptor Binding Domain Wuhan-Hu-1-Based Commercial Immunoassay Results Journal of medical virology 97(1):e70130 2025 [PMID: 39812228]
  100. Huyghe E, Abrams S, André E, Anseeuw K, Bernaert E, Bruynseels P, Cuypers L, De Schouwer P, Hilkens P, Keyaerts E, Laenen L, Maes J, Magerman K, Van de Gaer O, Verdonck A, Verstrepen W, Ombelet S, Naesens R. Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January-April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status Journal of medical virology 97(1):e70167 2025 [PMID: 39812123]
  101. Hafiz N, Hyun K, Tu Q, Knight A, Chow CK, Hespe C, Briffa T, Gallagher R, Reid CM, Hare DL, Zwar N, Woodward M, Jan S, Atkins ER, Laba TL, Halcomb E, Johnson T, Manandi D, Usherwood T, Redfern J. Implementation of a data-driven quality improvement program in primary care for patients with coronary heart disease: a mixed methods evaluation of acceptability, satisfaction, barriers and enablers Australian journal of primary health 31 2025 [PMID: 39808521]
  102. Vasquez R, Song JH, Mendoza RM, Hwang IC, Bagon BB, Engstrand L, Valeriano VD, Kang DK. Oral Immunisation With Non-GMO Surface Displayed SARS-CoV-2 Spike Epitopes on Bacteria-Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice Microbial biotechnology 18(1):e70073 2025 [PMID: 39797809]
  103. Mercuri E, Schmid L, Poethko-Müller C, Schlaud M, Kußmaul C, Ordonez-Cruickshank A, Haller S, Rexroth U, Hamouda O, Schaade L, Wieler LH, Gößwald A, Schaffrath Rosario A. Nationwide population-based infection- and vaccine-induced SARS-CoV-2 antibody seroprevalence in Germany in autumn/winter 2021/2022 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 30(1) 2025 [PMID: 39790070]
  104. Gökalp A, Üztemur S, Huang PC, Kartol A, Tsai HC, Dinç E, Griffiths MD, Lin CY. Pandemic or "Plandemic"?: The Mediating Role of Epistemic Justification Strategies in the Relationship Between COVID-19 Conspiracy Beliefs and COVID-19 Vaccine Conspiracy Beliefs Brain and behavior 15(1):e70275 2025 [PMID: 39789859]
  105. Devi A, Kumar Gupta P. Exploration of Bogdanov-Takens and Hopf bifurcation through coupling of nonlinear recovery with multiple reinfections of COVID-19 Chaos (Woodbury, N.Y.) 35(1) 2025 [PMID: 39787290]
  106. Sterling CE, Wilson NR, Harris DY, Smith EC. A yeast-assembled, plasmid-launched reverse genetics system for the murine coronavirus MHV-A59 The Journal of general virology 106(1) 2025 [PMID: 39785688]
  107. Willis DE, Narcisse MR, James L, Selig JP, Ason M, Scott AJ, Cornett LE, McElfish PA. Vaccine hesitancy or hesitancies? A latent class analysis of pediatric patients' parents Clinical and translational science 18(1):e70042 2025 [PMID: 39783703]
  108. Peramaiyan R, Anthony J, Varalakshmi S, Sekar AK, Ali EM, A AHS, Abdallah BM. Comparison of the role of vitamin D in normal organs and those affected by COVID-19 International journal of medical sciences 22(2):240-251 2025 [PMID: 39781525]
  109. Zhang S, Kong X, Zhen Q, Wei Y, Shi C, Ding S, Chen L, Dong C, Tian H, Li C, Zhou L, Zhang Y, Zhu F, Hu J, Bao C, Jin H, Xu K, Zhu L. Dynamic Changes and Trends of SARS-CoV-2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points Journal of medical virology 97(1):e70161 2025 [PMID: 39780477]
  110. Del Riccio M, Guida A, Boudewijns B, Heemskerk S, van Summeren J, Schneeberger C, Stelma F, van der Velden K, Timen A, Caini S. A Missed Opportunity? Exploring Changes in Influenza Vaccination Coverage During the COVID-19 Pandemic: Data From 12 Countries Worldwide Influenza and other respiratory viruses 19(1):e70057 2025 [PMID: 39778912]
  111. Smith B, Nair S, Wadei H, Mai M, Khamash H, Schinstock C, Liang Y, Abdelrheem A, Park W, Badley A, Stegall MD. Increased Mortality in Kidney Transplant Recipients During the Delta/Omicron Era of the COVID-19 Pandemic Despite Widespread Vaccination Clinical transplantation 39(1):e70071 2025 [PMID: 39777936]
  112. Ayuk HS, Arnold S, Pierzchalski A, Bauer M, Stojanovska V, Zenclussen AC. SARS-CoV-2 Activated Peripheral Blood Mononuclear Cells (PBMCs) Do Not Provoke Adverse Effects in Trophoblast Spheroids American journal of reproductive immunology (New York, N.Y. : 1989) 93(1):e70039 2025 [PMID: 39776066]
  113. Aglipay M, Maguire JL, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, Birken CS, Kwong JC. Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children Open forum infectious diseases 12(1):ofae718 2025 [PMID: 39758749]
  114. Ramirez JA, Hubler RA, Ali M, Gray SL, Carrico R, McNaughton CD, Wunderink RG, Dela Cruz CS, Chilson EL, Cané AD, Isturiz RE, Pride MW, Jodar L, Gessner BD, Grant LR. Streptococcus pneumoniae Serotype Distribution Among US Adults Hospitalized With Community-Acquired Pneumonia, 2019-2020 Open forum infectious diseases 12(1):ofae727 2025 [PMID: 39758745]
  115. Arrazola P, Fernández Prada M, Gil Á, Gómez Rial J, Hernán C, Menéndez R, Trilla A, Ortiz de Lejarazu R. New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons Enfermedades infecciosas y microbiologia clinica (English ed.) 43(1):36-46 2025 [PMID: 39755408]
  116. Chen J, Fan J, Malaviarachchi PA, Post SR, Lin Z, Zhang X, Qin Z. Alterations in Cellular Gene Expression Due to Co-Infection With Kaposi's Sarcoma-Associated Herpesvirus and SARS-CoV-2: Implications for Disease Severity Journal of medical virology 97(1):e70149 2025 [PMID: 39740042]
  117. Powers C, Corrente B, Joyce J, Stein W, Polydor S, Gunabushanam V, Khanna A, Silveira FP, Cruz RJ Jr. Evolving Impact of COVID-19 on Intestinal Transplant Recipients: A Single-Center Experience Clinical transplantation 39(1):e70065 2025 [PMID: 39739932]
  118. Hanage WP, Schaffner W. Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review Infectious diseases and therapy 14(Suppl 1):5-37 2025 [PMID: 39739200]
  119. Debbag R, Rudin D, Ceddia F, Watkins J. The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review Infectious diseases and therapy 14(Suppl 1):63-97 2025 [PMID: 39739199]
  120. Branche A, Ramesh M, Francis B. A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection Infectious diseases and therapy 14(Suppl 1):39-61 2025 [PMID: 39739198]
  121. Maggi S, Launay O, Dawson R. Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations Infectious diseases and therapy 14(Suppl 1):99-9114 2025 [PMID: 39739197]
  122. Amaral Y, Nardi AE, Marano D, Carioca da Costa AC, Moreira ME. Infant Passive Protection Against Coronavirus Through Exclusive Breastfeeding: A Cross-Sectional Study Nutrients 17(1) 2024 [PMID: 39796564]
  123. Remmele J, Helm PC, Li J, Oberhoffer-Fritz R, Bauer UMM, Ewert P. Twins with at least one with CHD and their immunisation status in direct comparison-are both twins complying with the German immunisation recommendations? Cardiovascular diagnosis and therapy 14(6):1108-1121 2024 [PMID: 39790207]
  124. Zhu J, Lai Y, Cheng M, Dash RC, Guo S, Guo J, Su Y, Wolek A, Issacs B, Liu Z, Li Q, Mishra N, Garmendia A, Hadden MK, Tian XC, He X, Tang Y. Discovery of small molecules against porcine reproductive and respiratory syndrome virus replication by targeting NendoU activity Journal of virology :e0203424 2024 [PMID: 39745451]
  125. Seo E, Shin EC, Jung MK. SARS-CoV-2 vaccine-elicited immune responses in solid organ transplant recipients Clinical transplantation and research 38(4):247-256 2024 [PMID: 39743229]
  126. Hollister J, Porter C, Sprissler R, Beitel SC, Romine JK, Uhrlaub JL, Grant L, Yoo YM, Fowlkes A, Britton A, Olsho LEW, Newes-Adeyi G, Fuller S, Zheng PQ, Gaglani M, Rose S, Dunnigan K, Naleway AL, Gwynn L, Caban-Martinez A, Schaefer Solle N, Tyner HL, Philips AL, Hegmann KT, Yoon S, Lutrick K, Burgess JL, Ellingson KD. Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance PloS one 19(12):e0306953 2024 [PMID: 39739951]
  127. Hassan MZ, Basher AK, Rahman MZ, Bhuiyan TR, Chowdhury F, Hossain MK, Rahman A, Islam MN, M Duca L, Kaydos-Daniels SC, A Dahl B, Qadri F, Ortiz N. Study protocol for COVID-19 breakthrough infections and vaccine-induced immune response among a cohort of healthcare workers, Bangladesh PloS one 19(12):e0316121 2024 [PMID: 39739828]
  128. Leniz J, Hernández-Jaña S, Soto M, Arenas E, Margozzini P, Suarez F, Capurro D, Rojas MP, Bambs C. Association between demographic, clinical characteristics and severe complications by SARS-CoV-2 infection in a community-based healthcare network in Chile PloS one 19(12):e0314376 2024 [PMID: 39775294]
  129. Sato Y, Kawachi I, Saijo Y, Yoshioka E, Osaka K, Tabuchi T. Correlates of COVID-19 conspiracy theory beliefs in Japan: A cross-sectional study of 28,175 residents PloS one 19(12):e0310673 2024 [PMID: 39774423]
  130. Laarman C, Hahné SJ, de Melker HE, Knol MJ. SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022 PloS one 19(12):e0311229 2024 [PMID: 39774370]
  131. Mojgani N, Dadar M, Shahali Y, Simal-Gandara J, Kumar P, Ashique S, Bhowmick M, Kumar H. Antioxidant Nutraceuticals: Their Adjunct Role in the Management of COVID-19 Infections and Post-COVID Syndrome Infectious disorders drug targets 2024 [PMID: 39757610]
  132. Gao M, Zhang Z, Yao G, Zhang L, Duan A, Zhang Y, Wang Y, Zhao J, Zhang J. Design, synthesis, and biological evaluation of novel 2'-deoxy-2'-spirooxetane-7-deazapurine nucleoside analogs as anti-SARS-CoV-2 agents Antiviral research 234:106060 2024 [PMID: 39743047]
  133. Vincent R, Rapoport D, Balchandani P, Borrello J, Schotsaert M, Karlicek R, Laghlali G, Warang P, Park S, Singh G, Morgan I, Paredes J, Rathnasinghe R, Wolf J, García-Sastre A. Portable UV-C device to treat high flow of infectious aerosols generated during clinical respiratory care Scientific reports 14(1):31799 2024 [PMID: 39738586]
  134. Bosman M, Cordon Y, Duran-Sala M, Gabbanelli L, García-Pérez C, Jordan X, Manera M, Masjuan P, Medina A, Mir LM, Oròs A, Vitagliano V. An agent based simulation of COVID-19 history in Catalonia using extensive real datasets Scientific reports 14(1):31858 2024 [PMID: 39738339]
  135. Jazi K, Rahimi M, Hasani F, Shirmohammadi M, Masoumi M. Unilateral Anterior Scleritis Following the Booster Shot of Inactivated COVID-19 (Sinopharm) Vaccine in a 52-Year-Old Woman: A Case Report Case reports in rheumatology 2024:6614757 2024 [PMID: 39759247]
  136. Pauly L, Residori C, Bulut H, Bulaev D, Ghosh S, O'Sullivan MP, Fritz JV, Vaillant M, Rommes B, Samuel R, Satagopam VP, Krüger R, Leist AK. Lessons learned from the COVID-19 pandemic: identifying hesitant groups and exploring reasons for vaccination hesitancy, from adolescence to late adulthood Frontiers in public health 12:1456265 2024 [PMID: 39776480]
  137. Xiong G, Huang X, Hu A, Meng Z, Cui J, Feng Y, Chen Z, Lu Y, Yang Q, Liu G. Optimizing Yeast Homologous Recombination for Splicing Large Coronavirus Genome Fragments International journal of molecular sciences 25(24) 2024 [PMID: 39769503]
  138. Liew WJM, Alkaff SA, Leong SY, Yee MZL, Hou HW, Czarny B. Cell Membrane- and Extracellular Vesicle-Coated Chitosan Methacrylate-Tripolyphosphate Nanoparticles for RNA Delivery International journal of molecular sciences 25(24) 2024 [PMID: 39769486]
  139. Maciel ABS, Pinto AS, Maia Silva B, Goulart CL, Silva LFA, Chaves AS, Mouta GS, Sato CMS, Valente J, Mwangi VI, de Melo GC, Monteiro W, Lacerda M, Arêas GPT, Sampaio VS, Costa AG, Almeida-Val F. Inflammatory discoveries two years after acute severe COVID-19: a longitudinal biomarker profile assessment in long COVID individuals in the Brazilian Amazon Frontiers in immunology 15:1520193 2024 [PMID: 39763676]
  140. Aguilar-Jimenez W, Rodriguez-Perea AL, Chvatal-Medina M, Velilla PA, Zapata-Builes W, Monsalve-Escudero LM, Zapata-Cardona MI, Tabares-Guevara JH, Rincón DS, Hernandez JC, Tabares Y, Lopez-Carvajal L, Rugeles MT. Immunogenicity of the CoronaVac vaccine in children: a real-world study Frontiers in immunology 15:1504935 2024 [PMID: 39763646]
  141. Timmesfeld N, Ihle P, Denz R, Meiszl K, Scholz K, Oberle D, Drechsel-Bäuerle U, Keller-Stanislawski B, Diebner HH, Meyer I. Determining the feasibility of linked claims and vaccination data for a COVID-19 vaccine pharmacoepidemiological study in Germany-RiCO feasibility study protocol BMJ open 14(12):e086074 2024 [PMID: 39806631]
  142. Pasik K, Domańska-Blicharz K, Iwan E, Bomba A. High-throughput sequencing as a potential tool in the quality control of infectious bronchitis vaccines Journal of veterinary research 68(4):475-485 2024 [PMID: 39776691]
  143. Nabeemeeah F, Sabet N, Otwombe K, Hlongwane K, Mlambo LM, Moloantoa T, Wong M, Mangena P, Abraham P, Swanepoel F, Moosa F, von Gottberg A, Cohen C, Southern J, Fletcher M, Dunne E, Ndungane-Tlakula B, Begier E, Gray S, Gessner BD, Naidoo J, Milovanovic M, Variava E, Martinson N. Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev Study BMJ open 14(12):e080553 2024 [PMID: 39806691]
  144. Joseph G, Margalit I, Weiss-Ottolenghi Y, Rubin C, Murad H, Gardner RC, Barda N, Ben-Shachar E, Indenbaum V, Gilboa M, Alroy-Preis S, Kreiss Y, Lustig Y, Regev-Yochay G. Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort Study Viruses 16(12) 2024 [PMID: 39772261]
  145. Song JH, Jang S, Choi JW, Hwang S, Kim KH, Kim HY, Park SC, Lee W, Lee JY. Characterization of Site-Specific N- and O-Glycopeptides from Recombinant Spike and ACE2 Glycoproteins Using LC-MS/MS Analysis International journal of molecular sciences 25(24) 2024 [PMID: 39769415]
  146. Sun YS, Xu F, Zhu HP, Xia Y, Li QM, Luo YY, Lu HJ, Wu BB, Wang Z, Yao PP, Zhou Z. Development of a two-component recombinant vaccine for COVID-19 Frontiers in immunology 15:1514226 2024 [PMID: 39759508]
  147. Naka T, Funato M, Yasuda K, Nakayama T, Kuru S. Association of the immunogenicity of intramuscular SARS-CoV-2 mRNA vaccination with computed tomography muscle images in patients with muscular disorders Frontiers in immunology 15:1479321 2024 [PMID: 39759503]
  148. von der Schulenburg P, Behrens GMN, Hoffmann M, Linke A, Nehlmeier I, Kempf AM, Stankov M, Lütgehetmann M, Jahnke-Triankowski J, Addo MM, Fischer L, Lohse AW, Pöhlmann S, Schulze Zur Wiesch J, Sterneck M. Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients Viruses 16(12) 2024 [PMID: 39772248]
  149. Gonzalez-Carmona MA, Schmitz AM, Berger M, Baier LI, Gorny JG, Sadeghlar F, Anhalt T, Zhou X, Zhou T, Mahn R, Möhring C, Linnemann T, Schmid M, Strassburg CP, Boesecke C, Rockstroh JK, Eis-Hübinger AM, Monin MB. Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures International journal of molecular sciences 25(24) 2024 [PMID: 39769379]
  150. Grewe I, Friedrich M, Dieck ML, Spohn M, Ly ML, Krähling V, Mayer L, Mellinghoff SC, Rottstegge M, Kraemer R, Volz A, Becker S, Fathi A, Dahlke C, Weskamm LM, Addo MM. MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity Frontiers in immunology 15:1500615 2024 [PMID: 39749328]
  151. Brangel P, Tureli S, Mühlemann B, Liechti N, Zysset D, Engler O, Hunger-Glaser I, Ghiga I, Mattiuzzo G, Eckerle I, Bekliz M, Rössler A, Schmitt MM, Knabl L, Kimpel J, Tort LFL, de Araujo MF, de Oliveira ACA, Caetano BC, Siqueira MM, Budt M, Gensch JM, Wolff T, Hassan T, Selvaraj FA, Hermanus T, Kgagudi P, Crowther C, Richardson SI, Bhiman JN, Moore PL, Cheng SMS, Li JKC, Poon LLM, Peiris M, Corman VM, Drosten C, Lai L, Hunsawong T, Rungrojcharoenkit K, Lohachanakul J, Sigal A, Khan K, Thiel V, Barut GT, Ebert N, Mykytyn AZ, Owusu Donkor I, Aboagye JO, Nartey PA, Van Kerkhove MD, Cunningham J, Haagmans BL, Suthar MS, Smith D, Subissi L. A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories Viruses 16(12) 2024 [PMID: 39772242]
  152. Chen Y, Tian F, Hu S, Liu X. Development and Evaluation of a Newcastle Disease Virus-like Particle Vaccine Expressing SARS-CoV-2 Spike Protein with Protease-Resistant and Stability-Enhanced Modifications Viruses 16(12) 2024 [PMID: 39772238]
  153. Otten T, Jiang X, Gupta MK, Vadaq N, Cleophas-Jacobs M, Dos Santos JC, Groenendijk A, Vos W, van Eekeren LE, Blaauw MJT, Meeder EMG, Richel O, Matzaraki V, van Lunzen J, Joosten LAB, Li Y, Xu CJ, van der Ven A, Netea MG. Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands Frontiers in immunology 15:1459593 2024 [PMID: 39744634]
  154. Fam BSO, Cadore NA, Sbruzzi R, Feira MF, Giudicelli GC, de Almeida LGP, Gerber AL, Guimarães APC, Vasconcelos ATR, Pereira AC, Pereira LV, Hünemeier T, Camey SA, Vianna FSL. SARS-CoV-2 strains and clinical profiles of COVID-19 patients in a Southern Brazil hospital Frontiers in immunology 15:1444620 2024 [PMID: 39744633]
  155. Martac I, Beer SA, Schenk A, Ahmad O, Maier CP, Demirel G, Preuß B, Klein R, Stanger AMP, Besemer B, Hensen L, Lengerke C. SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy Frontiers in immunology 15:1510942 2024 [PMID: 39744626]
  156. Rodrigues NCP, Andrade MKN. Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term Frontiers in medicine 11:1495428 2024 [PMID: 39744527]
  157. Tahir IM, Kumar V, Faisal H, Gill A, Kumari V, Tahir HM, Haque MA. Contagion comeback: unravelling the measles outbreak across the USA Frontiers in public health 12:1491927 2024 [PMID: 39744360]
  158. Muchangi JM, Mturi J, Mukasa H, Kithuki K, Kosgei SJ, Kanyangi LM, Moraro R, Kamau S, Nankanja M. Influence of government policies on handwashing and vaccine uptake in Kenya, Uganda, and Tanzania to prevent and control COVID-19: a systematic review Frontiers in public health 12:1417866 2024 [PMID: 39744350]
  159. Muminov M, Tsiferova N, Pshenichnov E, Ermatova K, Charishnikova O, Abdullaev A, Levitskaya Y, Dalimova D, Mvs S, Tomar G, Dewle A, Choudhari P, Wangikar A, Jadhav A, Mule M, Wangikar P, Abdurakhmonov I, Turdikulova S. Development, Pre-Clinical Safety, and Immune Profile of RENOVAC-A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine Vaccines 12(12) 2024 [PMID: 39772081]
  160. Li X, Zhu H, Xu P, Zhang J, Wang Z, He H, Shen F, Jiang Y, Shen L, Xiang J, Yang L, Yang C, Jiang H, Gao G, Jin J, Shen H, Wang Y, Wu L, Qian C, Liu D, Qiu W, Li Q, Chen Y, Lin F, Liu Y. A comprehensive immune repertoire signature distinguishes pulmonary infiltration in SARS-CoV-2 Omicron variant infection Frontiers in immunology 15:1486352 2024 [PMID: 39742285]
  161. Zhong Y, Kottaiswamy A, Ang CX, Li HE, Yap GC, Tay CJX, Osman NE, Roslan SNB, Tan CW, Yap WC, Ang EY, Chan Ng PPL, Yap HK, Lu L, Aw MM, Karthik SV, Quak SH, Quah TC, Tham EH, Shek LP, Ooi EE. Reduced durability of hybrid immunity to SARS-CoV-2 in immunocompromised children Frontiers in immunology 15:1502598 2024 [PMID: 39742263]
  162. Brandi R, Paganelli A, D'Amelio R, Giuliani P, Lista F, Salemi S, Paganelli R. mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases Vaccines 12(12) 2024 [PMID: 39772079]
  163. Nogareda F, Ghiselli M, Velandia-González M, de Mucio B, Jara J, Couto P, Rodriguez A, Rondy M, Vicari A, Ozturk MH, Goldin S, Vilajeliu A, Leidman E, Patel J, Carlton J, Fowlkes AL, Azziz-Baumgartner E, Salas Peraza D, Ropero AM. Seasonal Influenza Vaccination Programs in the Americas: A Platform for Sustainable Life-Course Immunization and Its Role for Pandemic Preparedness and Response Vaccines 12(12) 2024 [PMID: 39772075]
  164. Gasparello J, Papi C, Marzaro G, Macone A, Zurlo M, Finotti A, Agostinelli E, Gambari R. Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine Molecules (Basel, Switzerland) 29(24) 2024 [PMID: 39770027]
  165. López D, Zumárraga J. Bioinformatic Tools for Studying the Cellular Immune Response to SARS-CoV-2, Vaccine Efficacy, and Future Pandemics at the Global Population Level International journal of molecular sciences 25(24) 2024 [PMID: 39769240]
  166. Kusunoki H. Current Status and Significance of Additional Vaccination with COVID-19 Vaccine in Japan-Considerations from Antibody Levels from Hybrid Immunity and Public Perceptions Vaccines 12(12) 2024 [PMID: 39772074]
  167. Nakatani E, Morioka H, Kikuchi T, Fukushima M. Behavioral and Health Outcomes of mRNA COVID-19 Vaccination: A Case-Control Study in Japanese Small and Medium-Sized Enterprises Cureus 16(12):e75652 2024 [PMID: 39803093]
  168. Christodoulakis A, Bouloukaki I, Aravantinou-Karlatou A, Zografakis-Sfakianakis M, Tsiligianni I. Vaccine Hesitancy and Associated Factors Amongst Health Professionals: A Scoping Review of the Published Literature Vaccines 12(12) 2024 [PMID: 39772072]
  169. Mansou Y, Kumaran M, Farmer G, Kemp K, Usman H, Strong D, Mutwiri GK, Sikdar KC. Reported Adverse Events Following SARS-CoV-2 Vaccinations in the Canadian Province of Alberta and Associated Risk Factors: A Retrospective Cohort Study Vaccines 12(12) 2024 [PMID: 39772070]
  170. Athavale A, Gaur A, Ahmed N, Subramaniam A, Dandotiya J, Raj S, Upadhyay SK, Samal S, Pandey AK, Rai RC, Awasthi A. Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2 Vaccines 12(12) 2024 [PMID: 39772064]
  171. Kutumbetov L, Myrzakhmetova B, Tussipova A, Zhapparova G, Tlenchiyeva T, Bissenbayeva K, Zhapar K, Zhugunissov K, Nurabayev S, Kerimbayev A. Safety and Immunogenicity of the Live Attenuated Vaccine QazCOVID-Live Against Coronavirus Infection COVID-19: Pre-Clinical Study Results Vaccines 12(12) 2024 [PMID: 39772061]
  172. Ali S, Giovanetti M, Johnston C, Urdaneta-Páez V, Azarian T, Cella E. From Emergence to Evolution: Dynamics of the SARS-CoV-2 Omicron Variant in Florida Pathogens (Basel, Switzerland) 13(12) 2024 [PMID: 39770354]
  173. Turčić M, Kraljević Pavelić S, Trivanović D, Pavelić K. Interaction of HERVs with PAMPs in Dysregulation of Immune Response Cascade Upon SARS-CoV-2 Infections International journal of molecular sciences 25(24) 2024 [PMID: 39769125]
  174. García-Bravo L, Prada A, Gutiérrez Larrañaga M, Espinosa Ros E, Almeida González D, Martín Martínez D, Rodríguez Sánchez T, Mingorance Gámez CG, Jurado Roger A, Aguado Álvarez R, Díaz Luna MLM, Rodríguez Hernández C, de la Varga-Martínez R, López-Cueto M, Julià Benique MR, San José-Cascón M, Quirant-Sánchez B, Martínez-Chamorro A, Marcaida-Benito G, Timoneda Timoneda PT, Fandos Sánchez M, Sacristán Enciso B, Mohamed Mohamed K, Guerra-Galán T, Villegas Á, Roncancio-Clavijo A, Rodríguez-Mahou M, Sánchez-Ramón S, Fernández-Arquero M, Candelas-Rodríguez G, Ochoa-Grullón J, On Behalf Of The Geai-Sei Group. Increased Risk of Myositis-Specific and Myositis-Associated Autoantibodies After COVID-19 Pandemic and Vaccination: A Spanish Multicenter Collaborative Study Biomedicines 12(12) 2024 [PMID: 39767707]
  175. Vega Rojas LJ, Ruíz-Manzano RA, Velasco-Elizondo MA, Carbajo-Mata MA, Hernández-Silva DJ, Rocha-Solache M, Hernández J, Pérez-Serrano RM, Zaldívar-Lelo de Larrea G, García-Gasca T, Mosqueda J. An Evaluation of the Cellular and Humoral Response of a Multi-Epitope Vaccine Candidate Against COVID-19 with Different Alum Adjuvants Pathogens (Basel, Switzerland) 13(12) 2024 [PMID: 39770342]
  176. Wang R, Xue J, Wei G, Zhang Y, Wang C, Li J, Geng X, Ostovan A, Chen L, Song Z. Fast and Sensitive Detection of Anti-SARS-CoV-2 IgG Using SiO(2)@Au@CDs Nanoparticle-Based Lateral Flow Immunoassay Strip Coupled with Miniaturized Fluorimeter Biomolecules 14(12) 2024 [PMID: 39766275]
  177. Quintero-Salgado E, Briseno-Ramírez J, Vega-Cornejo G, Damian-Negrete R, Rosales-Chavez G, De Arcos-Jiménez JC. Seasonal Shifts in Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses After the COVID-19 Pandemic: An Eight-Year Retrospective Study in Jalisco, Mexico Viruses 16(12) 2024 [PMID: 39772198]
  178. Grace SG, Wilson KN, Dorleans R, White ZS, Pu R, Gaudreault NN, Cool K, Campos Krauer JM, Franklin LE, Clemons BC, Subramaniam K, Richt JA, Lednicky JA, Long MT, Wisely SM. Low Prevalence of SARS-CoV-2 in Farmed and Free-Ranging White-Tailed Deer in Florida Viruses 16(12) 2024 [PMID: 39772194]
  179. Moraes MM, Campos GRF, Banho CA, Versiani AF, Lopes Dos Santos TMI, Parra MCP, Lobl E, Galvão TM, Vasilakis N, Nogueira ML. Spatiotemporal Dynamics of SARS-CoV-2 Variants During the First Year of the Pandemic Highlight the Earlier Emergence of the Zeta Variant of Interest in Brazil Pathogens (Basel, Switzerland) 13(12) 2024 [PMID: 39770329]
  180. Gillespie PF, Wang Y, Yin K, Groegler E, Cunningham N, Stiving AQ, Raffaele J, Marusa N, Tubbs CM, Loughney JW, Winters MA, Rustandi RR. Automated, Quantitative Capillary Western Blots to Analyze Host Cell Proteins in COVID-19 Vaccine Produced in Vero Cell Line Vaccines 12(12) 2024 [PMID: 39772035]
  181. Karami H, Sanaei P, Smirnova A. Balancing mitigation strategies for viral outbreaks Mathematical biosciences and engineering : MBE 21(12):7650-7687 2024 [PMID: 39807048]
  182. Olivero NB, Zappia VE, Gargantini P, Human-Gonzalez C, Raya-Plasencia L, Marquez J, Ortiz-Batsche L, Hernandez-Morfa M, Cortes PR, Ceschin D, Nuñez-Fernandez M, Perez DR, Echenique J. Genomic Evolution of the SARS-CoV-2 Omicron Variant in Córdoba, Argentina (2021-2022): Analysis of Uncommon and Prevalent Spike Mutations Viruses 16(12) 2024 [PMID: 39772187]
  183. Colonna G. Interactomic Analyses and a Reverse Engineering Study Identify Specific Functional Activities of One-to-One Interactions of the S1 Subunit of the SARS-CoV-2 Spike Protein with the Human Proteome Biomolecules 14(12) 2024 [PMID: 39766256]
  184. Kamil Q, Putri W, Ayulinda AP, Maelani I, Anwar S, Ichsan I, Pranata A, Mudatsir M, Syukri M, Rizal S, Razali R, Hamdani H, Kurniawan R, Irwansyah I, Sofyan SE, Harapan H. Comparative study of anti-SARS-CoV-2 receptor-binding domain total antibody titer before and after heterologous booster with mRNA-based COVID-19 vaccine Narra J 4(3):e788 2024 [PMID: 39816061]
  185. Hayati T, Kartinah NT, Wibowo H, Purwoko RY. Comparison of inflammatory mediator cytokine responses to inactivated virus platform COVID-19 vaccines between elderly and young adult populations Narra J 4(3):e1380 2024 [PMID: 39816048]
  186. Haddadin R, Molina S, Trad G, Ryan J, Gish R. Evaluating the Impact of Phosphatidylethanol Testing on Hospital Outcomes Gastroenterology research 17(5-6):205-211 2024 [PMID: 39802926]
  187. Park WB, Hwang YH, Kwon KT, Noh JY, Park SH, Song JY, Choo EJ, Choi MJ, Choi JY, Heo JY, Choi WS. COVID-19 Vaccination Recommendations for 2024-2025 in Korea Infection & chemotherapy 56(4):453-460 2024 [PMID: 39762924]
  188. Vilela L, Silva A, Cruz A, Sousa M, Costa M, Fonseca F, Campino S, Clark TG, Miranda A. Longitudinal Immunological Analysis of Portuguese Healthcare Workers Across the COVID-19 Pandemic Reveals Differences in the Humoral Immune Response to Vaccines Vaccines 12(12) 2024 [PMID: 39772020]
  189. Lorenzon A, Palandri L, Uguzzoni F, Cristofor CD, Lozza F, Rizzi C, Poluzzi R, Bertoli P, Zerzer F, Righi E. An Ecological Study Relating the SARS-CoV-2 Epidemiology with Health-Related, Socio-Demographic, and Geographical Characteristics in South Tyrol (Italy) International journal of environmental research and public health 21(12) 2024 [PMID: 39767445]
  190. Adewole OG, Omotoso KO. Gender differentials in access to medical services during COVID-19 lockdown: Insights from Nigeria African journal of reproductive health 28(11):115-134 2024 [PMID: 39756040]
  191. Jacob Khoury S, Zoabi Y, Scheinowitz M, Shomron N. Integrating Interpretability in Machine Learning and Deep Neural Networks: A Novel Approach to Feature Importance and Outlier Detection in COVID-19 Symptomatology and Vaccine Efficacy Viruses 16(12) 2024 [PMID: 39772174]
  192. Bbosa N, Kiiza R, Ssekagiri A, Namagembe HS, Nabirye SE, Kabuuka D, Rwankindo C, Kisakye A, Woldemariam YT, Kusemererwa S, Ongaria TA, Kakande A, Abaasa A, Kimbugwe G, Bosa HK, Driwale A, Mwenda JM, Worwui AK, Humphreys J, Cohuet S, Elliott AM, Ruzagira E, Kaleebu P, Ssemwanga D. Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination Viruses 16(12) 2024 [PMID: 39772170]
  193. Mattos M, Sacramento CQ, Ferreira AC, Fintelman-Rodrigues N, Pereira-Dutra FS, de Freitas CS, Gesto JSM, Temerozo JR, Silva APDD, Moreira MTG, Silva RSC, Silveira GPE, Pinto DP, Pereira HM, Fonseca LB, Alves Ferreira M, Blanco C, Viola JPB, Bou-Habib DC, Bozza PT, Souza TML. Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice Viruses 16(12) 2024 [PMID: 39772165]
  194. Di Stefano M, Mirabella L, Cotoia A, Faleo G, Rauseo M, Rizzo AC, Fiore JR, Cinnella G, Serviddio G. A Possible Protective Effect of IgA Against Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) in Bronchoalveolar Lavage in COVID-19 Patients Admitted to Intensive Care Unit Viruses 16(12) 2024 [PMID: 39772161]
  195. Evers P, Uguccioni SM, Ahmed N, Francis ME, Kelvin AA, Pezacki JP. miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors Viruses 16(12) 2024 [PMID: 39772154]
  196. Piltch-Loeb R, Nuñez Sahr J, Nelson LE, Vlahov D, Gershon RR. Barriers and Facilitators to Vaccine Equity Amidst the COVID-19 Vaccine Rollout in the United States International journal of environmental research and public health 21(12) 2024 [PMID: 39767429]
  197. Abdel-Salam AG, Boone EL, Ghanam R. Multivariate Techniques for Monitoring Susceptible, Exposed, Infected, Recovered, Death, and Vaccination Model Parameters for the COVID-19 Pandemic for Qatar International journal of environmental research and public health 21(12) 2024 [PMID: 39767422]
  198. Zhang Y, Tian C, Yu X, Yu G, Han X, Wang Y, Zhou H, Zhang S, Li M, Yang T, Sun Y, Tai W, Yin Q, Zhao G. Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo Vaccines 12(12) 2024 [PMID: 39771977]
  199. Laitin SMD, Baditoiu LM, Laza R, Besliu RS, Stoicescu ER, Gug M, Dumitru CS, Patrascu R. Impact of Vaccination Status on COVID-19 Severity and Pulmonary Involvement Medicina (Kaunas, Lithuania) 60(12) 2024 [PMID: 39768801]
  200. Mahlab-Guri K, Komarova I, Kadar L, Nemet S, Cohen R, Radian-Sade S, Tova A, Guri A, Rosenberg-Bezalel S, Elbirt D. COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV Viruses 16(12) 2024 [PMID: 39772116]
  201. Tong ST, Gottlieb M, Ebna Mannan I, Zheng Z, Sinha M, Santangelo M, Gatling K, Kean E, Watts P, Wang R, Montoy JC, Idris A, MacDonald S, Huebinger R, Hill M, O'Laughlin KN, Gentile NL, Dorney J, Malicki C, Elmore JG, Diaz Roldan K, Chan G, Lin Z, Weinstein RA, Stephens KA. Association of binge alcohol use with functional outcomes among individuals with COVID-19 infection Alcohol and alcoholism (Oxford, Oxfordshire) 60(1) 2024 [PMID: 39745829]
  202. Munoz FM, Beigi R, Posavad CM, Kelly C, Badell ML, Bunge K, Mulligan MJ, Parameswaran L, Richardson BA, Olsen-Chen C, Novak RM, Brady RC, DeFranco E, Gerber JS, Shriver M, Suthar MS, Coler R, Berube BJ, Kim SH, Piper JM, Miedema J, Pasetti M, Neuzil KM, Cardemil CV. Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum The Pediatric infectious disease journal 43(11):1065-1073 2024 [PMID: 39774938]
  203. Chowdhury S, Chowdhury NS. Association of Vestibular Neuritis Following COVID-19 Vaccination Discoveries (Craiova, Romania) 12(3):e195 2024 [PMID: 39749143]
  204. Gunaratne SH, Taylor BS, Zucker J, Wilkin TJ, Tieu HV. CROI 2024: The Challenges of Sustained Viral Suppression, Advanced HIV Disease, and Ending the HIV Epidemic Targets Topics in antiviral medicine 32(4):542-567 2024 [PMID: 39746674]
  205. Antar AAR, Peluso MJ. CROI 2024: Acute and Post-Acute COVID-19 Topics in antiviral medicine 32(4):523-541 2024 [PMID: 39746673]
  206. Meira DD, Zetum ASS, Casotti MC, Campos da Silva DR, de Araújo BC, Vicente CR, Duque DA, Campanharo BP, Garcia FM, Campanharo CV, Aguiar CC, Lapa CA, Alvarenga FDS, Rosa HP, Merigueti LP, Sant'Ana MC, Koh CWT, Braga RFR, Cruz RGCD, Salazar RE, Ventorim VDP, Santana GM, Louro TES, Louro LS, Errera FIV, Paula F, Altoé LSC, Alves LNR, Trabach RSDR, Santos EVWD, Carvalho EF, Chan KR, Louro ID. Bioinformatics and molecular biology tools for diagnosis, prevention, treatment and prognosis of COVID-19 Heliyon 10(14):e34393 2024 [PMID: 39816364]
  207. Motamedi-Sedeh F, Khorasani A, Lotfi M, Moosavi SM, Arbabi A, Hosseini SM. Role of gamma irradiation and disaccharide trehalose to induce immune responses in Syrian hamster model against Iranian SARS-CoV-2 virus isolate Veterinary research forum : an international quarterly journal 15(12):681-689 2024 [PMID: 39816636]
  208. Liu L, Chen H, Liu P, Ke X, Song J, Fang Y, Kong L, Xin X. Expression, purification and immunogenicity analyses of receptor binding domain protein of severe acute respiratory syndrome coronavirus 2 from delta variant Veterinary research forum : an international quarterly journal 15(12):657-663 2024 [PMID: 39816631]
  209. Yamada T, Sakai Y, Kashiwagi T, Iwabu M. Prognostic Factors for Mortality in Maintenance Hemodialysis Patients Infected with SARS-CoV-2 Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 91(6):520-526 2024 [PMID: 39756940]

Coxiella burnetii (Q fever)

  1. Modise-Tlotleng BM, Mpoloka SW, Settypalli TBK, Hyera J, Kgotlele T, Kumile K, Sechele ME, Raboloko OO, Marobela-Raborokgwe C, Viljoen GJ, Cattoli G, Lamien CE. Molecular Testing of Zoonotic Bacteria in Cattle, Sheep, and Goat Abortion Cases in Botswana Microorganisms 12(12) 2024 [PMID: 39770846]

Cryptosporidium parvum

  1. Wang Y, Chang Y, Yin F, Kang C, Meng Y, Xu F, Liu Y, Zhang Y, Wu C, Fan S, Zhao J. Structural analyses of Cryptosporidium parvum epitopes reveal a novel scheme of decapeptide binding to H-2K(b) Journal of structural biology :108168 2025 [PMID: 39809366]
  2. Sigalapalli DK, Groustra S, Fenwick MK, Zigweid R, Hulverson MA, Owsley E, Khim M, Shibata S, Van Voorhis WC, Staker BL, Fan E. Structure guided modification of 2-chloro-5-(ethyl-phenyl-sulfamoyl)-N-[2-(2-oxo-pyrrolidin-1-yl)-phenyl]-benzamide to afford selective inhibitors of Cryptosporidium parvum N-myristoyltransferase Bioorganic & medicinal chemistry letters 119:130092 2025 [PMID: 39778753]

Eastern equine encephalitis virus

  1. Larkin CI, Dunn MD, Shoemaker JE, Klimstra WB, Faeder JR. A detailed kinetic model of Eastern equine encephalitis virus replication in a susceptible host cell bioRxiv : the preprint server for biology 2024 [PMID: 39764060]

Ebola virus

  1. Cross RW, Woolsey C, Prasad AN, Borisevich V, Agans KN, Deer DJ, Harrison MB, Dobias NS, Fenton KA, Cihlar T, Nguyen AQ, Babusis D, Bannister R, Vermillion MS, Chu VC, Geisbert TW. Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates Nature medicine 2025 [PMID: 39805309]
  2. Ajelli M, Muyembe JJ, Touré A, Diallo A, Litvinova M, Merler S, Mulangu S, Bagayoko A, Bah A, Bah I, Barry A, Barry F, Chérif M, Condé D, Diallo AA, Diallo F, Diakité M, Doré K, Mapan KA, Koundouno T, Onivogui PK, Lamah F, Maneno H, Nomou A, Sekouba K, Sani I, Soumah A, Sy MM, Gsell PS, Halloran ME, Henao-Restrepo AM, Fall IS, Ryan MJ, Salama P, Vespignani A, Longini IM Jr. Vaccination Strategies for Ebola in the Democratic Republic of Congo: The WHO-Ebola Modeling Collaboration International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases :107779 2025 [PMID: 39805421]
  3. Lundstrom K. Self-amplifying RNA virus vectors for drug delivery Expert opinion on drug delivery :1-15 2025 [PMID: 39757959]
  4. Khan A, Sayaf AM, Mohammad A, Alshabrmi FM, Benameur T, Wei DQ, Yeoh KK, Agouni A. Discovery of anti-Ebola virus multi-target inhibitors from traditional Chinese medicine database using molecular screening, biophysical investigation, and binding free energy calculations Journal of infection and public health 18(2):102636 2024 [PMID: 39798213]
  5. Tamilarasi W, Balamurugan BJ. New reverse sum Revan indices for physicochemical and pharmacokinetic properties of anti-filovirus drugs Frontiers in chemistry 12:1486933 2024 [PMID: 39749221]
  6. Semancik CS, Whitworth HS, Price MA, Yun H, Postler TS, Zaric M, Kilianski A, Cooper CL, Kuteesa M, Talasila S, Malkevich N, Gupta SB, Francis SC. Seroprevalence of Antibodies to Filoviruses with Outbreak Potential in Sub-Saharan Africa: A Systematic Review to Inform Vaccine Development and Deployment Vaccines 12(12) 2024 [PMID: 39772055]
  7. Massey SE. The Growing Phenomenon of 'Frozen' Virus Genome Sequences and Their Likely Origin in Research Facility Escapes Microorganisms 12(12) 2024 [PMID: 39770614]
  8. Cohen CA, Zumbrun EE, Writer JV, Bonagofski LG, Shoemaker CJ, Zeng X, Blancett CD, Douglas CE, Delp KL, Taylor-Howell CL, Carey BD, Ravulapalli S, Raymond JL, Dye JM, Herbert AS. A Small-Particle Aerosol Model of Ebolavirus Zaire Infection in Ferrets Viruses 16(12) 2024 [PMID: 39772117]

Escherichia coli

  1. Watcharavongtip P, Jermsutjarit P, Tantituvanont A, Nilubol D. Development of a differentiating of infected from vaccinated animal (DIVA) ELISA to detect antibodies against Senecavirus A in pigs using two expression systems of non-structural proteins The veterinary quarterly 45(1):1-11 2025 [PMID: 39773099]
  2. Sloboda S, Ge X, Jiang D, Su L, Wiens GD, Beveridge CA, Duchaud E, McBride MJ, Rochat T, Zhu Y. Methylation of foreign DNA overcomes the restriction barrier of Flavobacterium psychrophilum and allows efficient genetic manipulation Applied and environmental microbiology :e0144824 2025 [PMID: 39791877]
  3. Hernández-Mercado A, Barrón-García CB, Romo-Amador J, Córdova-Dávalos LE, Jiménez M, Fernández-Ruiz JC, Castañeda-Delgado JE, Montes de Oca-Luna R, Salinas E, Cervantes-García D. Evaluation of an F Protein-Based Recombinant Protein for Immunization Against Respiratory Syncytial Virus Viral immunology 2025 [PMID: 39791530]
  4. Bian X, Chen Y, Zhang W, Liu X, Lei M, Yuan H, Li M, Liu Q, Kong Q. Salmonella Typhimurium derived OMV nanoparticle displaying mixed heterologous O-antigens confers immunogenicity and protection against STEC infections in mice Microbial cell factories 24(1):8 2025 [PMID: 39773741]
  5. Blum M, Geurtsen J, Herweijer E, Sarnecki M, Spiessens B, Reynolds Diogo G, Hermans P, Thelwall S, Bhattacharya A, Verstraeten T, Poolman J, Hope R. Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017 Epidemiology and infection 153:e4 2025 [PMID: 39757943]
  6. Siamalube B, Ehinmitan E, Ngotho M, Onguso J, Runo S. Simple and Fail-safe Method to Transform Miniprep Escherichia coli Strain K12 Plasmid DNA Into Viable Agrobacterium tumefaciens EHA105 Cells for Plant Genetic Transformation Bio-protocol 15(1):e5174 2025 [PMID: 39803315]
  7. Setiabudiawan TP, Apriani L, Verrall AJ, Utami F, Schneider M, Indrati AR, Halim PP, Kaplonek P, Malca H, Lee JS, Moorlag SJCFM, de Bree LCJ, Mourits VP, Joosten LAB, Netea MG, Alisjahbana B, McNamara RP, Alter G, van Laarhoven A, Ussher JE, Sharples K, Koeken VACM, Hill PC, van Crevel R. Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in Indonesia Nature communications 16(1):309 2025 [PMID: 39747050]
  8. Landman WJM, van Eck JHH, Schellekens M, Feberwee A. Safety and efficacy of an inactivated tetravalent water-in-oil emulsion Escherichia coli vaccine against the E. coli peritonitis syndrome Avian pathology : journal of the W.V.P.A :1-23 2025 [PMID: 39743962]
  9. Tan J, Wang YX, Kang ZF, Huang JN, Li HQ, Wu CC, Li N, Zhang FF, Tan MF. Molecular characterization of avian pathogenic Escherichia coli strains in Jiangxi Province, China, and development of polyvalent inactivated vaccines Poultry science 104(2):104766 2025 [PMID: 39756108]
  10. Baliban SM, Shridhar S, Luo K, Kolasny J, Hyun S, Zhao Z, Tennant SM, Cross AS. A core glycolipid vaccine elicits cross-reactive antibodies against Salmonella spp. and protects against invasive nontyphoidal Salmonella disease in mice The Journal of infectious diseases 2024 [PMID: 39739873]
  11. Gette MS, Sudarev VV, Osipov SD, Laptenkova EV, Bazhenov SV, Zagryadskaya YA, Tilinova OM, Dronova EA, Kuklina DD, Al Ebrahim R, Fedorov DM, Kurkin TS, Semenov YS, Bondarev NA, Skoi VV, Okhrimenko IS, Li N, Kuklin AI, Manukhov IV, Ryzhykau YL, Uversky VN, Vlasov AV. Ferritin-based hybrid macromolecules experience unusual shift of stoichiometry distribution International journal of biological macromolecules :139335 2024 [PMID: 39743119]
  12. Xiong G, Huang X, Hu A, Meng Z, Cui J, Feng Y, Chen Z, Lu Y, Yang Q, Liu G. Optimizing Yeast Homologous Recombination for Splicing Large Coronavirus Genome Fragments International journal of molecular sciences 25(24) 2024 [PMID: 39769503]
  13. Chun HS, Park C, Nho D, Lee R, Cho SY, Kim CJ, Lee DG. Effect of Antimicrobial Wipes on Hospital-Associated Bacterial and Fungal Strains Infection & chemotherapy 56(4):522-533 2024 [PMID: 39762928]
  14. Shen K, Wang G, Yang H, Kang X, Yang L, Yuan Y, Wang X, Wang Z. Generation of soluble, immunoreactive recombinant JEV E protein through a simplified inclusion body extraction and refolding approach in vitro Heliyon 10(14):e34372 2024 [PMID: 39816339]

Francisella tularensis (Tularemia)

  1. Avril A, Guillier S, Rasetti-Escargueil C. Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies Microorganisms 12(12) 2024 [PMID: 39770824]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Voeller AS, Johannessen A, Abebe ZZ, Adugna W, Gamkrelidze I, Seyoum E, Gebremedhin LT, Meselu MG, Nigussie SA, Silesh A, Razavi H, Razavi-Shearer D, Tirsite G, Desalegn H. The Disease and Economic Burden of HBV and HCV in Ethiopia Journal of viral hepatitis 32(2):e14053 2025 [PMID: 39815994]
  2. Cohen P, Lambson BE, Mkhize NN, Moodley C, Yssel AEJ, Moyo-Gwete T, York T, Gwashu-Nyangiwe A, Ndabambi N, Thebus R, Juraska M, deCamp AC, Williamson BD, Magaret CA, Gilbert PB, Westfall D, Deng W, Mullins JI, Morris L, Williamson C, Moore PL. Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance Journal of virology :e0173024 2025 [PMID: 39817771]
  3. Termote M, Marques RC, Hyllner E, Guryleva MV, Henskens M, Brutscher A, Baken IJL, Dopico XC, Gasull AD, Murrell B, Stamatatos L, Westerberg LS, Dosenovic P. Antigen affinity and site of immunization dictate B cell recall responses Cell reports 44(1):115221 2025 [PMID: 39817910]
  4. Lovane L, Larsson GL, Tulsidás S, Carrilho C, Andersson S, Karlsson C. Endocervical adenocarcinomas and HPV genotyping in an HIV endemic milieu - a retrospective study BMC women's health 25(1):20 2025 [PMID: 39815240]
  5. Zhang G, Yang H, Bian J, Asilibieke S, Tian T, Lynn HS, Dai J. Infection and Persistent Infection of Human Papillomavirus Among HIV-Negative Men Who Have Sex with Men in Xinjiang, China: A Prospective Cohort Study AIDS and behavior 2025 [PMID: 39812751]
  6. Friedland BA, Gundacker H, Achilles SL, Chen BA, Hoesley C, Richardson BA, Kelly CW, Piper J, Johnson S, Devlin B, Steytler J, Kleinbeck K, Dangi B, Friend C, Song M, Mensch B, van der Straten A, Jacobson C, Hendrix CW, Brown J, Blithe D, Hiller SL. Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development PloS one 20(1):e0312957 2025 [PMID: 39808648]
  7. Shahhamzehei N, Abdelfatah S, Omer EA, Riedl M, Meesters C, Schwarzer-Sperber HS, Sutter K, Bringmann G, Schwarzer R, Efferth T. Diketopiperazine/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based library Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 183:117841 2025 [PMID: 39809126]
  8. Vernon SD, Zheng T, Do H, Marconi VC, Jason LA, Singer NG, Natelson BH, Sherif ZA, Bonilla HF, Taylor E, Mullington JM, Ashktorab H, Laiyemo AO, Brim H, Patterson TF, Akintonwa TT, Sekar A, Peluso MJ, Maniar N, Bateman L, Horwitz LI, Hess R. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study Journal of general internal medicine 2025 [PMID: 39804551]
  9. Moscicki AB, Flowers L, Huchko MJ, Long ME, MacLaughlin KL, Murphy J, Spiryda LB, Scheckel CJ, Gold MA. Updated Review for Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection Journal of lower genital tract disease 2025 [PMID: 39804372]
  10. Morgado JA, Medina MG, Guevara RN, Carballo M, Torres JR, Carrión-Nessi FS, Forero-Peña DA. Brief communication: gaps and opportunities in HIV research in Venezuela AIDS research and therapy 22(1):5 2025 [PMID: 39800723]
  11. Alles M, Gunasena M, Isckarus C, De Silva I, Board S, Mulhern W, Collins PL, Demberg T, Liyanage NPM. Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform NPJ vaccines 10(1):5 2025 [PMID: 39799133]
  12. Caldera F, Kane S, Long M, Hashash JG. Non-colorectal Cancer Screening and Vaccinations in Patients with Inflammatory Bowel Disease: Expert Review Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2025 [PMID: 39800200]
  13. Farinre O, Anaya T, King AC, Endrias K, Hébert AH, Hill AL, Jean S, Wood JS, Ehnert S, Liang S, Laird GM, Mason RD, Roederer M, Safrit JT, Mavigner M, Chahroudi A. SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques PLoS pathogens 21(1):e1012863 2025 [PMID: 39792949]
  14. Buckley M, Araínga M, Maiorino L, Pires IS, Kim BJ, Michaels KK, Dye J, Qureshi K, Zhang Y, Mak H, Steichen JM, Schief WR, Villinger F, Irvine DJ. Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates Molecular therapy : the journal of the American Society of Gene Therapy 2025 [PMID: 39797396]
  15. Gorman J, Du R, Lai YT, Ahmadi MS, King HAD, Song K, Manalang K, Gonelli CA, Schramm CA, Cheng C, Nguyen R, Ambrozak D, Druz A, Shen CH, Yang Y, Douek DC, Kwong PD, Roederer M, Mason RD. Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor class Cell reports 44(1):115163 2025 [PMID: 39792559]
  16. Swanson OM, Zhang QE, Van Itallie E, Tian M, Brown AR, Harris C, Kapingidza AB, Rhodes B, Smith LM, Venkatayogi S, Cronin K, Frazier M, Parks R, Bar M, Jiang C, Martin Beem JS, Cheng HL, Davis J, McGovern K, Newman A, Edwards RJ, Cain D, Alam SM, Wiehe K, Saunders KO, Acharya P, Alt F, Haynes BF, Azoitei ML. An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutations Science translational medicine 17(780):eadr2218 2025 [PMID: 39772772]
  17. Claiborne DT, Detwiler Z, Docken SS, Borland TD, Cromer D, Simkhovich A, Ophinni Y, Okawa K, Bateson T, Chen T, Hudson W, Trifonova R, Davenport MP, Ho TW, Boutwell CL, Allen TM. High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection Nature communications 16(1):446 2025 [PMID: 39774003]
  18. Hidalgo-Tenorio C, Calle-Gómez I, Moya R, Omar M, Lopez-Hidalgo J, Rodriguez-Granges J, Muñoz L, García-Martinez C. Prevalence and incidence of HPV-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people living with HIV (PLHIV) AIDS (London, England) 2025 [PMID: 39764768]
  19. Ntawuyamara E, Ingabire T, Yandemye I, Ndayikeza P, Bhandari B, Liang YH. Assessing healthcare workers' knowledge and confidence in the diagnosis, management and prevention of Monkeypox World journal of clinical cases 13(1):99884 2025 [PMID: 39764536]
  20. Reverón DR, Flora-Noda DM, Soto LM, Dolande M, Frey J, Chaurio A, Ruiz-Alayón BD, Caldera J, Carrión-Nessi FS, Forero-Peña DA. Disseminated nocardiosis in a patient with AIDS and B-cell non-Hodgkin's lymphoma: a case report BMC infectious diseases 25(1):30 2025 [PMID: 39762755]
  21. Rahmouni M, Clerc SL, Spadoni JL, Labib T, Tison M, Medina-Santos R, Bensussan A, Tamouza R, Deleuze JF, Zagury JF. Deep analysis of the major histocompatibility complex genetic associations using covariate analysis and haploblocks unravels new mechanisms for the molecular etiology of Elite Control in AIDS BMC immunology 26(1):1 2025 [PMID: 39762745]
  22. Ponnan SM, Govindaraj S, Velu V. Role of follicular homing natural killer cells in HIV infection Current opinion in HIV and AIDS 2025 [PMID: 39773847]
  23. Kaul R, Leidner AJ, Chesson HW. Trends in costs of routinely recommended vaccines in the United States, 2001-2023 Vaccine 47:126667 2025 [PMID: 39754832]
  24. Pollock KM, Cheeseman HM, McFarlane LR, Day S, Tolazzi M, Turner HL, Joypooranachandran J, Shramko K, Dispinseri S, Mundsperger P, Bontjer I, Lemm NM, Coelho S, Tanaka M, Cole T, Korber B, Katinger D, Sattentau QJ, Ward AB, Scarlatti G, Sanders RW, Shattock RJ. Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth EBioMedicine 112:105544 2025 [PMID: 39753033]
  25. Giersing B, Mo AX, Hwang A, Baqar S, Earle K, Ford A, Deal C, Dull P, Friede M, Hall BF. Meeting summary: Global vaccine and immunization research forum, 2023 Vaccine 46:126686 2025 [PMID: 39752894]
  26. Díaz-Maneh A, Pérez-Rubio P, Granes CR, Bosch-Molist L, Lavado-García J, Gòdia F, Cervera L. Targeted knockdown of ATM, ATR, and PDEδ increases Gag HIV-1 VLP production in HEK293 cells Applied microbiology and biotechnology 109(1):1 2025 [PMID: 39747723]
  27. Nardo D, Maddox EG, Riley JL. Cell therapies for viral diseases: a new frontier Seminars in immunopathology 47(1):5 2025 [PMID: 39747475]
  28. Metelmann S, Thompson A, Donten A, Oke S, Sun S, Borrow R, Xu F, Vivancos R, Decraene V, Pellis L, Hall I. A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infections PloS one 20(1):e0316184 2025 [PMID: 39746102]
  29. . Glenda Gray: overcoming obstacles, driving innovation Bulletin of the World Health Organization 103(1):7-8 2025 [PMID: 39781005]
  30. Morris DJ, Gorman J, Zhou T, Lora J, Connell AJ, Li H, Liu W, Roark RS, Campion MS, Carey JW, Habib R, Li Y, Martella CL, Park Y, Singh A, Sowers KJ, Teng IT, Wang S, Chohan N, Ding W, Lauer C, Lewis E, Mason RD, Rando JM, Peyton L, Schramm CA, Wagh K, Korber B, Seaman MS, Douek DC, Haynes BF, Kulp DW, Roederer M, Hahn BH, Kwong PD, Shaw GM. Transient glycan-shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques bioRxiv : the preprint server for biology 2024 [PMID: 39803442]
  31. Cui X, Xie Z, Wu Z, Xu LQ. Current trends and future directions in probiotics research for HIV/AIDS Frontiers in microbiology 15:1444552 2024 [PMID: 39802658]
  32. Farrell-Sherman A, de la Force N, Prator C, Valieris R, Azam W, Da Silva I, Deeks SG, Thanh C, Bosch R, Henrich TJ, Cohn L. Inflammatory Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia bioRxiv : the preprint server for biology 2024 [PMID: 39763863]
  33. Hill M, Garcia LR, Nguyen E, Korolkova A, Cohn L, Rodriguez A, Hoh R, Deeks SG, Peluso MJ, Sauceda JA, Dubé K. Evaluating the psychosocial experiences of participants in HIV cure research before, during, and after analytical treatment interruptions: A longitudinal qualitative study in the United States Social science & medicine (1982) 366:117644 2024 [PMID: 39754855]
  34. Voogd L, Riou C, Scriba TJ, van Wolfswinkel M, van Meijgaarden KE, Franken KLMC, Wilkinson RJ, Ottenhoff THM, Joosten SA. HLA-E/Mtb specific CD4(+) and CD8(+) T cells have a memory phenotype in individuals with TB infection Frontiers in immunology 15:1505329 2024 [PMID: 39790998]
  35. Nabeemeeah F, Sabet N, Otwombe K, Hlongwane K, Mlambo LM, Moloantoa T, Wong M, Mangena P, Abraham P, Swanepoel F, Moosa F, von Gottberg A, Cohen C, Southern J, Fletcher M, Dunne E, Ndungane-Tlakula B, Begier E, Gray S, Gessner BD, Naidoo J, Milovanovic M, Variava E, Martinson N. Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev Study BMJ open 14(12):e080553 2024 [PMID: 39806691]
  36. Jost S, Reeves RK. Elephant in the room: natural killer cells don't forget HIV either Current opinion in HIV and AIDS 2024 [PMID: 39773904]
  37. Otten T, Jiang X, Gupta MK, Vadaq N, Cleophas-Jacobs M, Dos Santos JC, Groenendijk A, Vos W, van Eekeren LE, Blaauw MJT, Meeder EMG, Richel O, Matzaraki V, van Lunzen J, Joosten LAB, Li Y, Xu CJ, van der Ven A, Netea MG. Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands Frontiers in immunology 15:1459593 2024 [PMID: 39744634]
  38. Mitra D, Oldenburg DG, Forrest JC, Krug LT. Vaccination with a Replication-Dead Murine Gammaherpesvirus Lacking Viral Pathogenesis Genes Inhibits WT Virus Infection Viruses 16(12) 2024 [PMID: 39772237]
  39. Banerjee A, Dass D, Mukherjee S, Kaul M, Harshithkumar R, Bagchi P, Mukherjee A. The 'Oma's of the Gammas-Cancerogenesis by γ-Herpesviruses Viruses 16(12) 2024 [PMID: 39772235]
  40. Hare J, Nielsen M, Kiragga A, Ochiel D. Sustainable integration of artificial intelligence and machine learning approaches within the African infectious disease vaccine research and development ecosystem Frontiers in pharmacology 15:1499079 2024 [PMID: 39741624]
  41. Brandi R, Paganelli A, D'Amelio R, Giuliani P, Lista F, Salemi S, Paganelli R. mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases Vaccines 12(12) 2024 [PMID: 39772079]
  42. Bedwell GJ, Mqadi L, Kamerman P, Hutchinson MR, Parker R, Madden VJ. Inflammatory reactivity is unrelated to childhood adversity or provoked modulation of nociception medRxiv : the preprint server for health sciences 2024 [PMID: 39763518]
  43. . Early Efficacy and Safety of the Third Dose Inactivated COVID-19 Vaccine Among People Living With HIV: Erratum Journal of acquired immune deficiency syndromes (1999) 97(5):e30 2024 [PMID: 39792143]
  44. Bruzzesi E, Gandini F, Diotallevi S, Lolatto R, Cernuschi M, Candela C, Raccagni AR, Passini F, Tamburini AM, Burioni R, Castagna A, Nozza S. High Prevalence of High-Risk HPV Among People with and Without HIV: Insights into Risk Factors for Tailored Screening Approaches Microorganisms 12(12) 2024 [PMID: 39770774]
  45. Kien CA, Ebai R, Fombad FF, Esofi F, Ntuh AN, Ouam E, Gandjui NVT, Chunda VC, Ekanya R, Nietcho FN, Foyet JV, Nchang LC, Magha C, Njouendou AJ, Enyong P, Hoerauf A, Ritter M, Wanji S. Large-scale production of Mansonella perstans infective larvae from engorged Culicoides milnei Frontiers in tropical diseases 5 2024 [PMID: 39811392]
  46. Smith JC, Arunachalam PS, Legere TH, Cavacini LA, Hunter E, Pulendran B, Amara RR, Kozlowski PA. Induction of Tier 2 HIV-Neutralizing IgA Antibodies in Rhesus Macaques Vaccinated with BG505.664 SOSIP Vaccines 12(12) 2024 [PMID: 39772048]
  47. Maswanganye CK, Mkhize PP, Matume ND. Mapping the HPV Landscape in South African Women: A Systematic Review and Meta-Analysis of Viral Genotypes, Microbiota, and Immune Signals Viruses 16(12) 2024 [PMID: 39772200]
  48. Cheng Z, Ma J, Zhao C. Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza Vaccines 12(12) 2024 [PMID: 39772044]
  49. Wang L, Vulesevic B, Vigano M, As'sadiq A, Kang K, Fernandez C, Samarani S, Anis AH, Ahmad A, Costiniuk CT. The Impact of HIV on B Cell Compartment and Its Implications for COVID-19 Vaccinations in People with HIV Vaccines 12(12) 2024 [PMID: 39772034]
  50. Li Y, Lin Y, Yi Y, Zhu N, Cui X, Li X. COVID-19 Vaccination and Transient Increase in CD4/CD8 Cell Counts in People with HIV: Evidence from China Vaccines 12(12) 2024 [PMID: 39772028]
  51. Sonawane A, Selvam D, Yue L, Nesakumar M, Vivekanandan S, Ashokkumar M, Hunter E, Hanna LE. Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation Viruses 16(12) 2024 [PMID: 39772167]
  52. Evers P, Uguccioni SM, Ahmed N, Francis ME, Kelvin AA, Pezacki JP. miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors Viruses 16(12) 2024 [PMID: 39772154]
  53. Shah MP, Morgan CJ, Beeson JG, Peach E, Davis J, McPake B, Wallace AS. Integrated Approaches for the Delivery of Maternal and Child Health Services with Childhood Immunization Programs in Low- and Middle-Income Countries: Systematic Review Update 2011-2020 Vaccines 12(12) 2024 [PMID: 39771975]
  54. Mahlab-Guri K, Komarova I, Kadar L, Nemet S, Cohen R, Radian-Sade S, Tova A, Guri A, Rosenberg-Bezalel S, Elbirt D. COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV Viruses 16(12) 2024 [PMID: 39772116]
  55. Munoz FM, Beigi R, Posavad CM, Kelly C, Badell ML, Bunge K, Mulligan MJ, Parameswaran L, Richardson BA, Olsen-Chen C, Novak RM, Brady RC, DeFranco E, Gerber JS, Shriver M, Suthar MS, Coler R, Berube BJ, Kim SH, Piper JM, Miedema J, Pasetti M, Neuzil KM, Cardemil CV. Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum The Pediatric infectious disease journal 43(11):1065-1073 2024 [PMID: 39774938]
  56. Gunaratne SH, Taylor BS, Zucker J, Wilkin TJ, Tieu HV. CROI 2024: The Challenges of Sustained Viral Suppression, Advanced HIV Disease, and Ending the HIV Epidemic Targets Topics in antiviral medicine 32(4):542-567 2024 [PMID: 39746674]
  57. He Q, Gao F, Dukes O, Delany-Moretlwe S, Zhang B. Generalizing the intention-to-treat effect of an active control from historical placebo-controlled trials: A case study of the efficacy of daily oral TDF/FTC in the HPTN 084 study Journal of the American Statistical Association 119(548):2478-2492 2024 [PMID: 39749107]

Marburg virus

  1. Yang W, Zhou W, Liang B, Hu X, Wang S, Wang Z, Wang T, Xia X, Feng N, Zhao Y, Yan F. A surrogate BSL2-compliant infection model recapitulating key aspects of human Marburg virus disease Emerging microbes & infections 14(1):2449083 2025 [PMID: 39745141]
  2. Cross RW, Woolsey C, Prasad AN, Borisevich V, Agans KN, Deer DJ, Harrison MB, Dobias NS, Fenton KA, Cihlar T, Nguyen AQ, Babusis D, Bannister R, Vermillion MS, Chu VC, Geisbert TW. Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates Nature medicine 2025 [PMID: 39805309]
  3. Xuan DTM, Yeh IJ, Liu HL, Su CY, Ko CC, Ta HDK, Jiang JZ, Sun Z, Lin HY, Wang CY, Yen MC. A comparative analysis of Marburg virus-infected bat and human models from public high-throughput sequencing data International journal of medical sciences 22(1):1-16 2025 [PMID: 39744175]
  4. Grewe I, Friedrich M, Dieck ML, Spohn M, Ly ML, Krähling V, Mayer L, Mellinghoff SC, Rottstegge M, Kraemer R, Volz A, Becker S, Fathi A, Dahlke C, Weskamm LM, Addo MM. MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity Frontiers in immunology 15:1500615 2024 [PMID: 39749328]
  5. Tamilarasi W, Balamurugan BJ. New reverse sum Revan indices for physicochemical and pharmacokinetic properties of anti-filovirus drugs Frontiers in chemistry 12:1486933 2024 [PMID: 39749221]
  6. Semancik CS, Whitworth HS, Price MA, Yun H, Postler TS, Zaric M, Kilianski A, Cooper CL, Kuteesa M, Talasila S, Malkevich N, Gupta SB, Francis SC. Seroprevalence of Antibodies to Filoviruses with Outbreak Potential in Sub-Saharan Africa: A Systematic Review to Inform Vaccine Development and Deployment Vaccines 12(12) 2024 [PMID: 39772055]
  7. Tscherne A, Kalodimou G, Kupke A, Rohde C, Freudenstein A, Jany S, Kumar S, Sutter G, Krähling V, Becker S, Volz A. Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans Vaccines 12(12) 2024 [PMID: 39771978]

Mycobacterium tuberculosis (tuberculosis)

  1. Chen D, Huang W, Shen L, Zhang J, Pan Z, Zhang C, Tang Y, Zhou Z, Tao J, Luo G, Zhang S, Zhou J, Xu S, Zhang M, Li Y, Fang Y, Zhao F, Huang L, Li H, Yang H, Lv H, Sha W, Yan B, Liu J, Zhang L. An mRNA vaccine induces antimycobacterial immunity by activating DNA damage repair and autophagy Molecular therapy. Nucleic acids 36(1):102402 2025 [PMID: 39759874]
  2. Palmer MV, Hwang S, Kanipe C, Putz EJ, Fernandes LGV, Didkowska A, Boggiatto PM. Immune responses of cattle vaccinated by various routes with Mycobacterium bovis Bacillus Calmette-Guérin (BCG) BMC veterinary research 21(1):19 2025 [PMID: 39815253]
  3. Xie W, Luo D, Soni V, Wang Z. Functional characterization of MMAR_1296 in Mycobacterium marinum and its potential as a vaccine candidate Vaccine 48:126720 2025 [PMID: 39809090]
  4. Korompis M, De Voss CJ, Li S, Richard A, Almujri SS, Ateere A, Frank G, Lemoine C, McShane H, Stylianou E. Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate Scientific reports 15(1):1886 2025 [PMID: 39805855]
  5. Chen Z, Feng L, Wang L, Zhang L, Zheng B, Fu H, Li F, Liu L, Lv Q, Deng R, Xu Y, Hu Y, Zheng J, Qin C, Bao L, Wang X, Jin Q. A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 Signal transduction and targeted therapy 10(1):14 2025 [PMID: 39800731]
  6. Thipkrua N, Disrathakit A, Chongsuvivatwong V, Mahasirimongkol S, Ruangchai W, Palittapongarnpim P, Chaiprasert A, Pungrassami P, Kamolwat P, Sutham K, Tossapornpong K, Sriplung H. A large geno-spatial cluster of multi-drug resistant tuberculosis outbreak in a western district of Thailand Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases :105715 2025 [PMID: 39800207]
  7. Chang R, Chen SY, Hsieh TY, Chen HY, Wang SI, Hung YM, Wei JC. Risk of SARS-CoV-2 infection and adverse outcomes among vaccinated patients with tuberculosis Public health 239:80-86 2025 [PMID: 39798219]
  8. Smith AA, Su H, Wallach J, Liu Y, Maiello P, Borish HJ, Winchell C, Simonson AW, Lin PL, Rodgers M, Fillmore D, Sakal J, Lin K, Vinette V, Schnappinger D, Ehrt S, Flynn JL. A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicity Nature microbiology 2025 [PMID: 39794473]
  9. Wang X, Su H, Wallach JB, Wagner JC, Braunecker BJ, Gardner M, Guinn KM, Howard NC, Klevorn T, Lin K, Liu YJ, Liu Y, Mugahid D, Rodgers M, Sixsmith J, Wakabayashi S, Zhu J, Zimmerman M, Dartois V, Flynn JL, Lin PL, Ehrt S, Fortune SM, Rubin EJ, Schnappinger D. Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal models Nature microbiology 2025 [PMID: 39794471]
  10. Xu D, Gu Y, Li G, Wang R, Xiao S, Duan H, Jiang J, Zhao X, Wan K, He X, Liu H, Lou Y. Evaluation of the cross-immunity between Mycobacterium tuberculosis and Mycobacterium abscessus in vitro BMC microbiology 25(1):9 2025 [PMID: 39789455]
  11. Nakayama DK. A Novel Microbe, Immunization Deaths, and Vaccination on Trial: BCG and the Lübeck Disaster of 1930 The American surgeon :31348251313994 2025 [PMID: 39788567]
  12. Seo H, Kim BJ, Oh J, Jung S, Lee JY, Kim BJ. Protection against tuberculosis by vaccination of secreted chorismate mutase (Rv1885c) combined with a hepatitis B virus (HBV)-derived peptide, Poly6, and alum adjuvants Vaccine 47:126710 2025 [PMID: 39787795]
  13. Owusu SK. Childhood Tuberculosis-Advances in Treatment and Prevention Pediatric pulmonology :e27375 2025 [PMID: 39777908]
  14. Isa MA, Kappo AP. Identification of novel 3-dehydroquinate dehydratase (DHQD) inhibitors for anti-tuberculosis activity: insights from virtual screening, molecular docking, and dynamics simulations In silico pharmacology 13(1):13 2025 [PMID: 39777139]
  15. Russell DG, Simwela NV, Mattila JT, Flynn J, Mwandumba HC, Pisu D. How macrophage heterogeneity affects tuberculosis disease and therapy Nature reviews. Immunology 2025 [PMID: 39774813]
  16. Reverón DR, Flora-Noda DM, Soto LM, Dolande M, Frey J, Chaurio A, Ruiz-Alayón BD, Caldera J, Carrión-Nessi FS, Forero-Peña DA. Disseminated nocardiosis in a patient with AIDS and B-cell non-Hodgkin's lymphoma: a case report BMC infectious diseases 25(1):30 2025 [PMID: 39762755]
  17. Zhao G, Sathkumara HD, Miranda-Hernandez S, Seifert J, Valencia-Hernandez AM, Puri M, Huang W, Toth I, Daly N, Skwarczynski M, Kupz A. A Modular Self-Assembling and Self-Adjuvanting Multiepitope Peptide Nanoparticle Vaccine Platform to Improve the Efficacy and Immunogenicity of BCG Small (Weinheim an der Bergstrasse, Germany) :e2406874 2025 [PMID: 39757706]
  18. Blanco FC, Marini MR, Klepp LI, Vázquez CL, García EA, Bigi MM, Canal A, Bigi F. Long-term evaluation in BALBc mice of a triple mutant of Mycobacterium bovis and the Bacillus Calmette-Guérin as potential vaccines against bovine tuberculosis Veterinary microbiology 302:110371 2025 [PMID: 39798450]
  19. Duangmixay S, Virachith S, Hübschen JM, Siphanthong P, Suthepmany S, Sayasone S, Black AP. Latent tuberculosis prevalence in healthcare workers in Laos: a cross-sectional study Tropical medicine and health 53(1):1 2025 [PMID: 39754226]
  20. Peters JM, Irvine EB, Makatsa MS, Rosenberg JM, Wadsworth MH 2nd, Hughes TK, Sutton MS, Nyquist SK, Bromley JD, Mondal R, Roederer M, Seder RA, Darrah PA, Alter G, Seshadri C, Flynn JL, Shalek AK, Fortune SM, Bryson BD. High-dose intravenous BCG vaccination induces enhanced immune signaling in the airways Science advances 11(1):eadq8229 2025 [PMID: 39742484]
  21. Setiabudiawan TP, Apriani L, Verrall AJ, Utami F, Schneider M, Indrati AR, Halim PP, Kaplonek P, Malca H, Lee JS, Moorlag SJCFM, de Bree LCJ, Mourits VP, Joosten LAB, Netea MG, Alisjahbana B, McNamara RP, Alter G, van Laarhoven A, Ussher JE, Sharples K, Koeken VACM, Hill PC, van Crevel R. Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in Indonesia Nature communications 16(1):309 2025 [PMID: 39747050]
  22. Dai T, Lu Y, Zhao R, Ning H, Kang J, Hao L, Li J, Chang Y, Bai Y. [Characteristics of immune response induced by mucosal immunization with recombinant adenovirus of Mycobacterium tuberculosis phosphodiesterase] Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 41(1):1-8 2025 [PMID: 39799419]
  23. Flores-Valdez MA. Intravenous vaccination with BCG against tuberculosis: Strengths and questions deserving further research Vaccine :126666 2025 [PMID: 39743457]
  24. Olson AM, Wood RC, Weigel KM, Yan AJ, Lochner KA, Dragovich RB, Luabeya AK, Yager P, Hatherill M, Cangelosi GA. High-sensitivity detection of Mycobacterium tuberculosis DNA in tongue swab samples Journal of clinical microbiology :e0114024 2024 [PMID: 39745422]
  25. Voogd L, Riou C, Scriba TJ, van Wolfswinkel M, van Meijgaarden KE, Franken KLMC, Wilkinson RJ, Ottenhoff THM, Joosten SA. HLA-E/Mtb specific CD4(+) and CD8(+) T cells have a memory phenotype in individuals with TB infection Frontiers in immunology 15:1505329 2024 [PMID: 39790998]
  26. Gong Y, Jia H, Dang W, Zhou T, He P, Wang X, Zhu B. Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717 Frontiers in immunology 15:1490003 2024 [PMID: 39763671]
  27. Nabeemeeah F, Sabet N, Otwombe K, Hlongwane K, Mlambo LM, Moloantoa T, Wong M, Mangena P, Abraham P, Swanepoel F, Moosa F, von Gottberg A, Cohen C, Southern J, Fletcher M, Dunne E, Ndungane-Tlakula B, Begier E, Gray S, Gessner BD, Naidoo J, Milovanovic M, Variava E, Martinson N. Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev Study BMJ open 14(12):e080553 2024 [PMID: 39806691]
  28. Liu JW, Tsai YW, Lai CC, Tang HJ. Post-pandemic epidemiological trends of respiratory infectious diseases in Taiwan: A retrospective analysis Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2024 [PMID: 39765452]
  29. Kalinich CC, Gonzalez FL, Osmaston A, Breban MI, Distefano I, Leon C, Sheen P, Zimic M, Coronel J, Tan G, Crudu V, Ciobanu N, Codreanu A, Solano W, Ráez J, Allicock OM, Chaguza C, Wyllie AL, Brandt M, Weinberger DM, Sobkowiak B, Cohen T, Grandjean L, Grubaugh ND, Redmond SN. Tiled Amplicon Sequencing Enables Culture-free Whole-Genome Sequencing of Pathogenic Bacteria From Clinical Specimens bioRxiv : the preprint server for biology 2024 [PMID: 39763738]
  30. Awad Mustafa S. Prevalence of BCG scar among vaccinated children and its correlation with Mantoux skin test at Omdawanban area, Sudan Tuberculosis (Edinburgh, Scotland) 151:102596 2024 [PMID: 39742566]
  31. Brandi R, Paganelli A, D'Amelio R, Giuliani P, Lista F, Salemi S, Paganelli R. mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases Vaccines 12(12) 2024 [PMID: 39772079]
  32. Santamaria C, Biegas KJ, Kim CY, Cabral J, Lee JR, Swarts BM, Siegrist MS. Trehalose dimycolate inhibits phagosome maturation and promotes intracellular M. tuberculosis growth via noncanonical SNARE interaction bioRxiv : the preprint server for biology 2024 [PMID: 39763847]
  33. Boucaid A, Zegmout A, Bhairis M, Amraoui M, Laaraje A, Kabiri EH, Rhorfi I. Epidemiology of Latent Tuberculosis in Moroccan Healthcare Workers: Prevalence Patterns and Predisposing Factors Cureus 16(12):e75740 2024 [PMID: 39816277]
  34. Nasiri MJ, Lutfy K, Venketaraman V. Challenges of Multidrug-Resistant Tuberculosis Meningitis: Current Treatments and the Role of Glutathione as an Adjunct Therapy Vaccines 12(12) 2024 [PMID: 39772057]
  35. Kondratyeva LG, Rakitina OA, Pleshkan VV, Kuzmich AI, Linge IA, Kondratieva SA, Snezhkov EV, Alekseenko IV, Sverdlov ED. The Cellular and Transcriptomic Early Innate Immune Response to BCG Vaccination in Mice Cells 13(24) 2024 [PMID: 39768135]
  36. Kien CA, Ebai R, Fombad FF, Esofi F, Ntuh AN, Ouam E, Gandjui NVT, Chunda VC, Ekanya R, Nietcho FN, Foyet JV, Nchang LC, Magha C, Njouendou AJ, Enyong P, Hoerauf A, Ritter M, Wanji S. Large-scale production of Mansonella perstans infective larvae from engorged Culicoides milnei Frontiers in tropical diseases 5 2024 [PMID: 39811392]
  37. Li Y, Lin Y, Yi Y, Zhu N, Cui X, Li X. COVID-19 Vaccination and Transient Increase in CD4/CD8 Cell Counts in People with HIV: Evidence from China Vaccines 12(12) 2024 [PMID: 39772028]
  38. Mondal S, Mandal A, Saha S, Chakrabarty PS, Datta P, Das D. Distribution of extrapulmonary tuberculosis in CBNAAT samples received in a tertiary care hospital - A record-based study Journal of family medicine and primary care 13(12):5704-5707 2024 [PMID: 39790800]
  39. Sonawane A, Selvam D, Yue L, Nesakumar M, Vivekanandan S, Ashokkumar M, Hunter E, Hanna LE. Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation Viruses 16(12) 2024 [PMID: 39772167]
  40. Wang J, Zhao Z, Wang Q, Shi J, Wong DW, Cheung JC. Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review Vaccines 12(12) 2024 [PMID: 39771997]
  41. Naveed M, Waseem M, Mahkdoom I, Ali N, Asif F, Hassan JU, Jamil H. Transient comparison of techniques to counter multi-drug resistant bacteria: prime modules in curation of bacterial infections Frontiers in antibiotics 2:1309107 2023 [PMID: 39816650]

Nipah virus

  1. Yu F, Younas Khan M, Bilal Riaz M, Ullah S, Farooq M. Assessing the global dynamics of Nipah infection under vaccination and treatment: A novel computational modeling approach PloS one 20(1):e0309360 2025 [PMID: 39808615]
  2. Ong HM, Ibrahim PAS, Chong CN, Tan CT, Schee JP, Avumegah MS, Román RG, Cherian NG, Wong WF, Chang LY. Malaysia outbreak survivors retain detectable Nipah antibodies and memory B cells after 25 years The Journal of infection :106398 2025 [PMID: 39755279]
  3. Li JD, Liu YQ, He RQ, Huang ZG, Huang WY, Huang H, Liu ZH, Chen G. Understanding and addressing the global impact: A systematic review and cross-sectional bibliometric analysis of Langya henipavirus and pre-existing severe henipaviruses Journal of infection and public health 18(2):102631 2024 [PMID: 39778464]
  4. Brandi R, Paganelli A, D'Amelio R, Giuliani P, Lista F, Salemi S, Paganelli R. mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases Vaccines 12(12) 2024 [PMID: 39772079]
  5. Suden P, Singh I, Chopra C, Mehta M, Chandra R, Bhushan I. Identification of CD8+ Immunogenic Peptides for Vaccine Design against Nipah Virus in Humans Iranian journal of public health 53(12):2789-2801 2024 [PMID: 39759209]

Plasmodium falciparum (Malaria)

  1. Amen A, Yoo R, Fabra-García A, Bolscher J, Stone WJR, Bally I, Dergan-Dylon S, Kucharska I, de Jong RM, de Bruijni M, Bousema T, King CR, MacGill RS, Sauerwein RW, Julien JP, Poignard P, Jore MM. Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats eLife 13 2025 [PMID: 39817720]
  2. Marques RF, Ábrahám E, Muramatsu H, Bargieri DY, Pardi N, Lipinszki Z. Expression and purification of E140 protein antigen fragments of Plasmodium vivax and Plasmodium berghei for serological assays FEBS open bio 2025 [PMID: 39815669]
  3. Singh H, Kirar M, Yadav M, Dahiya N, Janjoter S, Sehrawat N. Molecular characterization and bioinformatic analysis of SGU protein in Anopheles culicifacies as target for transmission blocking activity Immunologic research 73(1):34 2025 [PMID: 39810016]
  4. Braunack-Mayer L, Nekkab N, Malinga J, Kelly SL, Ansah E, Moehrle JJ, Penny MA. Therapeutic development to accelerate malaria control through intentional intervention layering Malaria journal 24(1):12 2025 [PMID: 39806410]
  5. Dolan B, Correa Gaviria T, Dong Y, Cresswell P, Dimopoulos G, Chuang YM, Fikrig E. mosGILT antibodies interfere with Plasmodium sporogony in Anopheles gambiae Nature communications 16(1):592 2025 [PMID: 39799117]
  6. Shukla S, Kushwah S, Mani A. Targeting Malaria's Achilles' Heels: A Review of Plasmodium Life Cycle Vulnerabilities for Drug Discovery Current topics in medicinal chemistry 2025 [PMID: 39810526]
  7. Yoon KW, Eom GD, Mao J, Kim MJ, Heo SI, Kang HJ, Chu KB, Moon EK, Quan FS. Protection induced by recombinant vaccinia virus targeting the ROP4 of Toxoplasma gondii in mice Experimental parasitology 269:108900 2025 [PMID: 39800042]
  8. Pirahmadi S, Zargar M, Pourhashem Z, Vand-Rajabpour H, Sani JJ, Yousefi H, Afzali S, Zakeri S, Mehrizi AA. Selection of combination adjuvants for enhanced immunogenicity of a recombinant CelTOS vaccine against Plasmodium falciparum Biochemical and biophysical research communications 748:151310 2025 [PMID: 39809136]
  9. Venkatraman N, Silman D, Bellamy D, Stockdale L, Bowyer G, Edwards NJ, Griffiths O, Lopez FR, Powlson J, Mair C, Folegatti PM, Datoo MS, Morter R, Minassian AM, Poulton I, Collins KA, Brod F, Angell-Manning P, Berrie E, Brendish N, Glenn G, Fries L, Baum J, Blagborough AM, Roberts R, Lawrie AM, Angus B, Lewis DJM, Faust SN, Ewer KJ, Hill AVS. R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study The Lancet. Microbe :100867 2025 [PMID: 39805301]
  10. Wilke ABB, Farina P, Ajelli M, Canale A, Dantas-Torres F, Otranto D, Benelli G. Human migrations, anthropogenic changes, and insect-borne diseases in Latin America Parasites & vectors 18(1):4 2025 [PMID: 39789650]
  11. Cao Y, da Silva Araujo M, Lorang CG, Dos Santos NAC, Tripathi A, Vinetz J, Kumar N. Distinct immunogenicity outcomes of DNA vaccines encoding malaria transmission-blocking vaccine target antigens Pfs230D1M and Pvs230D1 Vaccine 47:126696 2025 [PMID: 39787798]
  12. Dereje N, Fallah MP, Tajudeen R, Kaseya J. A new RH5.1/Matrix-M candidate malaria vaccine: a promising finding to boost malaria elimination in Africa The Lancet. Infectious diseases 2025 [PMID: 39793595]
  13. Mishra A, Qamar F, Ashrafi K, Fatima S, Samim M, Mohmmed A, Abdin MZ. Emerging nanotechnology-driven drug delivery solutions for malaria: Addressing drug resistance and improving therapeutic success International journal of pharmaceutics 670:125163 2025 [PMID: 39788401]
  14. Eltahir EA, Ibnouf MAM, Ibnouf MMAM, Ahmed MH, Imam MH, Ahmed A. The clinical range and management of spontaneous rupture of the pathological malarial spleen (SRPMS): A short case series from Sudan International journal of surgery case reports 127:110818 2025 [PMID: 39778495]
  15. Sibomana O, Bukuru J, Saka SA, Uwizeyimana MG, Kihunyu AM, Obianke A, Damilare SO, Bueh LT, Agbelemoge BOG, Oveh RO. Routine malaria vaccination in Africa: a step toward malaria eradication? Malaria journal 24(1):1 2025 [PMID: 39757179]
  16. Goswami D, Kappe SHI. Setting sights on a single-shot malaria vaccine Nature medicine 2025 [PMID: 39753973]
  17. Roozen GVT, van Schuijlenburg R, Hensen ADO, Koopman JPR, Lamers OAC, Geurten FJA, Sijtsma JC, Baalbergen E, Janse JJ, Chevalley-Maurel S, Naar CM, Bezemer S, Kroeze H, van de Stadt HJF, de Visser B, Meij P, Tihaya MS, Colstrup E, Iliopoulou E, de Bes-Roeleveld HM, Wessels E, van der Stoep MYEC, Janse CJ, Murugan R, Franke-Fayard BMD, Roestenberg M. Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial Nature medicine 2025 [PMID: 39753962]
  18. Dacon C, Moskovitz R, Swearingen K, Da Silva Pereira L, Flores-Garcia Y, Aleshnick M, Kanatani S, Flynn B, Molina-Cruz A, Wollenberg K, Traver M, Kirtley P, Purser L, Dillon M, Bonilla B, Franco A, Petros S, Kritzberg J, Tucker C, Paez GG, Gupta P, Shears MJ, Pazzi J, Edgar JM, Teng AA, Belmonte A, Oda K, Doumbo S, Krymskaya L, Skinner J, Li S, Ghosal S, Kayentao K, Ongoiba A, Vaughan A, Campo JJ, Traore B, Barillas-Mury C, Wijayalath W, Idris A, Crompton PD, Sinnis P, Wilder BK, Zavala F, Seder RA, Wilson IA, Tan J. Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein Science (New York, N.Y.) 387(6729):eadr0510 2025 [PMID: 39745947]
  19. Giersing B, Mo AX, Hwang A, Baqar S, Earle K, Ford A, Deal C, Dull P, Friede M, Hall BF. Meeting summary: Global vaccine and immunization research forum, 2023 Vaccine 46:126686 2025 [PMID: 39752894]
  20. Bediako VB, Ackah JA, Yankey TJ, Okyere J, Acheampong E, Owusu BA, Agbemavi W, Nwameme AU, Kamau EM, Asampong E. Factors associated with vaccine default in Southern Ghana based on data from the RTSS malaria vaccine trial in Cape Coast Scientific reports 15(1):251 2025 [PMID: 39747227]
  21. Olumide AT, Aigbiremo OM, Yetunde O, Agnes AM, Naomi OA, Victoria AO, Samson TK. Awareness, Acceptability and Factors Influencing Malaria Vaccine Uptake Among Caregivers of Children Under 5 in South-Western Nigeria Child: care, health and development 51(1):e70029 2025 [PMID: 39749414]
  22. Schmid M, Beyeler R, Caldelari R, Rehmann R, Heussler V, Roques M. Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development PloS one 19(12):e0316164 2024 [PMID: 39739824]
  23. Noranate N, Sripanomphong J, Mphande-Nyasulu FA, Chaorattanakawee S. Plasmodium falciparum surf4.1 in clinical isolates: From genetic variation and variant diversity to in silico design immunopeptides for vaccine development PloS one 19(12):e0312091 2024 [PMID: 39775228]
  24. Proellochs NI, Andolina C, Ramjith J, Stoter R, van Gemert GJ, Graumans W, Campino S, Vanheer LN, Okitwi M, Tumwebaze PK, Conrad MD, Clark TG, Fidock DA, Menard D, Mok S, Bousema T. Gametocyte production and transmission fitness of African and Asian Plasmodium falciparum isolates with differential susceptibility to artemisinins bioRxiv : the preprint server for biology 2024 [PMID: 39763803]
  25. Gbedande K, Ibitokou SA, Endrino MJD, Yap GS, Brown MG, Stephens R. Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection iScience 27(12):111468 2024 [PMID: 39758993]
  26. Venkatraman N, Tiono AB, Bowyer G, Bellamy DG, Stockdale LK, Powlson J, Collins KA, Coulibaly S, Datoo MS, Silman D, Ouedraogo A, Nébié I, Imoukhuede EB, Brod F, Folegatti P, Dickinson-Craig E, Jamieson S, Bougouma EC, Wright D, Diarra A, Bliss CM, Morter R, Glenn G, Fries LF, Reimer JM, Lövgren-Bengtsson K, Baker M, Poulton I, Moyle S, Berrie E, Green N, Mukhopadhyay E, Viebig NK, Angus B, Lawrie A, Roberts R, Gilbert SC, Lewis DJM, Sirima SB, Ewer KJ, Hill AVS. Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials The Lancet. Microbe :100868 2024 [PMID: 39805302]
  27. Brandi R, Paganelli A, D'Amelio R, Giuliani P, Lista F, Salemi S, Paganelli R. mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases Vaccines 12(12) 2024 [PMID: 39772079]
  28. Kien CA, Ebai R, Fombad FF, Esofi F, Ntuh AN, Ouam E, Gandjui NVT, Chunda VC, Ekanya R, Nietcho FN, Foyet JV, Nchang LC, Magha C, Njouendou AJ, Enyong P, Hoerauf A, Ritter M, Wanji S. Large-scale production of Mansonella perstans infective larvae from engorged Culicoides milnei Frontiers in tropical diseases 5 2024 [PMID: 39811392]
  29. Shah MP, Morgan CJ, Beeson JG, Peach E, Davis J, McPake B, Wallace AS. Integrated Approaches for the Delivery of Maternal and Child Health Services with Childhood Immunization Programs in Low- and Middle-Income Countries: Systematic Review Update 2011-2020 Vaccines 12(12) 2024 [PMID: 39771975]
  30. Ngoh IA, Mane K, Manneh J, Bojang F, Jawara AS, Akenji TN, Anong DN, D'Alessandro U, Amambua-Ngwa A. Transcriptome analysis reveals molecular targets of erythrocyte invasion phenotype diversity in natural Plasmodium falciparum isolates from Cameroon Frontiers in parasitology 3:1370615 2024 [PMID: 39817175]
  31. Maina M, Musundi S, Kuja J, Waweru H, Kiboi D, Kanoi BN, Gitaka J. Genetic variation of the Plasmodium falciparum circumsporozoite protein in parasite isolates from Homabay County in Kenya Frontiers in parasitology 3:1346017 2024 [PMID: 39817167]
  32. Naung MT, Martin E, Wong W, Razook Z, Utama D, Guy AJ, Harrison ST, Cowman AF, Lin E, Kiniboro B, Laman M, Mueller I, Barry AE. Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the Plasmodium falciparum population of Papua New Guinea Frontiers in parasitology 2:1288867 2023 [PMID: 39816834]

Salmonella

  1. Chen K, Li L, Wang N, Zhou Z, Pan P, Xu C, Sun D, Li J, Dai C, Kuang D, Liao M, Zhang J. Newly identified c-di-GMP pathway putative EAL domain gene STM0343 regulates stress resistance and virulence in Salmonella enterica serovar Typhimurium Veterinary research 56(1):13 2025 [PMID: 39815376]
  2. Emerson LE, Bhimani S, Rainey AL, Maurelli AT, Ferraro MJ. Evaluating small extracellular vesicle-based vaccination across heterologous Salmonella strains isolated from wastewater Infection and immunity :e0048524 2025 [PMID: 39804074]
  3. Igomu EE, Mamman PH, Adamu J, Muhammad M, Woziri AO, Sugun MY, Benshak JA, Anyika KC, Sam-Gyang R, Ehizibolo DO. Immunoinformatics design of a novel multiepitope vaccine candidate against non-typhoidal salmonellosis caused by Salmonella Kentucky using outer membrane proteins A, C, and F PloS one 20(1):e0306200 2025 [PMID: 39792829]
  4. Li W, Li YA, Wang S, Shi H. A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein Vaccine 47:126700 2025 [PMID: 39778475]
  5. Bian X, Chen Y, Zhang W, Liu X, Lei M, Yuan H, Li M, Liu Q, Kong Q. Salmonella Typhimurium derived OMV nanoparticle displaying mixed heterologous O-antigens confers immunogenicity and protection against STEC infections in mice Microbial cell factories 24(1):8 2025 [PMID: 39773741]
  6. Hayman KP, Sacquitne C, Rowson AD, Burkhardt DT, Peterson MP, Straub DE, McGill JL, Gorden PJ. Randomized controlled trial comparing the immunogenicity of experimental Salmonella Dublin siderophore receptor vaccines in calves American journal of veterinary research :1-8 2025 [PMID: 39773372]
  7. Aganja RP, Kwon J, Senevirathne A, Lee JH. Deletion of pagL and arnT genes involved in LPS structure and charge modulation in the Salmonella genome confer reduced endotoxicity and retained efficient protection against wild-type Salmonella Gallinarum challenge in chicken Veterinary research 56(1):2 2025 [PMID: 39755658]
  8. Munjita SM, Kalonda A, Mubemba B, Vanaerschot M, Tato C, Mwakibete L, Tembo J, Chitanga S, Changula K, Kajihara M, Muleya W, Sawa H, Takada A, Bates M, Munsaka S, Simulundu E. Evidence of multiple bacterial, viral, and parasitic infectious disease agents in Mastomys natalensis rodents in riverine areas in selected parts of Zambia Infection ecology & epidemiology 15(1):2441537 2025 [PMID: 39764202]
  9. Baliban SM, Shridhar S, Luo K, Kolasny J, Hyun S, Zhao Z, Tennant SM, Cross AS. A core glycolipid vaccine elicits cross-reactive antibodies against Salmonella spp. and protects against invasive nontyphoidal Salmonella disease in mice The Journal of infectious diseases 2024 [PMID: 39739873]
  10. Yeh HY, Read QD. Immune responses of chickens against recombinant Salmonella enterica serotype Heidelberg FimA and FimW fimbriae and FliD and FlgK flagellar proteins Veterinary immunology and immunopathology 280:110870 2024 [PMID: 39788047]
  11. Monson MS, Gurung M, Bearson BL, Whelan SJ, Trachsel JM, Looft T, Sylte MJ, Bearson SMD. Evaluating two live-attenuated vaccines against Salmonella enterica serovar Reading in turkeys: reduced tissue colonization and cecal tonsil transcriptome responses Frontiers in veterinary science 11:1502303 2024 [PMID: 39748866]
  12. Bucarey SA, Maldonado LD, Duarte F, Hidalgo AA, Sáenz L. Oral Vaccine Formulation for Immunocastration Using a Live-Attenuated Salmonella ΔSPI2 Strain as an Antigenic Vector Vaccines 12(12) 2024 [PMID: 39772060]
  13. Neelawala RN, Edison LK, Kariyawasam S. Pre-Harvest Non-Typhoidal Salmonella Control Strategies in Commercial Layer Chickens Animals : an open access journal from MDPI 14(24) 2024 [PMID: 39765482]
  14. Bodman-Harris O, Rollier CS, Iqbal M. Approaches to Enhance the Potency of Vaccines in Chickens Vaccines 12(12) 2024 [PMID: 39771998]
  15. Chagas DB, Santos FDS, de Oliveira NR, Bohn TLO, Dellagostin OA. Recombinant Live-Attenuated Salmonella Vaccine for Veterinary Use Vaccines 12(12) 2024 [PMID: 39771981]
  16. Alhumaidan OS. Comprehensive review of salmonellosis: current status of the disease and future perspectives Italian journal of food safety 13(4):12904 2024 [PMID: 39749178]

Shigella

  1. Ogwel B, Mzazi VH, Awuor AO, Okonji C, Anyango RO, Oreso C, Ochieng JB, Munga S, Nasrin D, Tickell KD, Pavlinac PB, Kotloff KL, Omore R. Derivation and validation of a clinical predictive model for longer duration diarrhea among pediatric patients in Kenya using machine learning algorithms BMC medical informatics and decision making 25(1):28 2025 [PMID: 39815316]
  2. Desalegn G, Abrahamson C, Ross Turbyfill K, Pill-Pepe L, Bautista L, Tamilselvi CS, Dunn D, Kapoor N, Sullinger B, Herrera M, Oaks EV, Fairman J, Pasetti MF. A broad spectrum Shigella vaccine based on VirG(53)(-)(353) multiepitope region produced in a cell-free system NPJ vaccines 10(1):6 2025 [PMID: 39805874]

Variola major (Smallpox)

  1. Abdel-Rahman SM, Bayıcı BZ, Keske Ş, Kuşkucu M, Özsürekçi Y, Rimoin AW, Rodriguez-Morales AJ, Ergönül Ö. Mpox primer for clinicians: what makes the difference in 2024? Current opinion in infectious diseases 2025 [PMID: 39813011]
  2. Naga NG, Nawar EA, Mobarak AA, Faramawy AG, Al-Kordy HMH. Monkeypox: a re-emergent virus with global health implications - a comprehensive review Tropical diseases, travel medicine and vaccines 11(1):2 2025 [PMID: 39810237]
  3. Teodoro LI, Ovsyannikova IG, Poland GA, Kennedy RB. Examining homology between MPXV and immunogenic VACV-derived peptides Vaccine 48:126708 2025 [PMID: 39809088]
  4. Eslamkhah S, Aslan ES, Yavas C, Akcalı N, Batur LK, Abuaisha A, Yildirim EE, Solak M, White KN. Mpox virus (MPXV): comprehensive analysis of pandemic risks, pathophysiology, treatments, and mRNA vaccine development Naunyn-Schmiedeberg's archives of pharmacology 2025 [PMID: 39777535]
  5. Forbes N, Montroy J, Salvadori MI, Klein K. Summary of the National Advisory Committee on Immunization (NACI) Statement-Updated guidance on Imvamune in the context of a routine immunization program Canada communicable disease report = Releve des maladies transmissibles au Canada 51(1):1-6 2025 [PMID: 39781236]
  6. Galetti SC, Gadoth A, Halbrook M, Tobin NH, Ferbas KG, Rimoin AW, Aldrovandi GM. Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers with childhood and adulthood exposures Vaccine 46:126661 2025 [PMID: 39752895]
  7. Ahmadi S, Amirzadeh M, Ahmadi M, Soleiman-Meigooni S. From Outbreaks to Artificial Intelligence: A Comprehensive Review of Monkeypox Virus Epidemiology, Diagnosis, Treatment, Vaccination, and Deep Learning Applications Journal of tropical medicine 2024:6688914 2024 [PMID: 39764350]
  8. Avril A, Guillier S, Rasetti-Escargueil C. Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies Microorganisms 12(12) 2024 [PMID: 39770824]
  9. Phipps K, Yates J, Pettit J, Bialosuknia S, Hunt D, DuPuis AP 2nd, Payne A, Lee W, McDonough KA. Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine-Naive Persons after JYNNEOS Vaccination Emerging infectious diseases 31(2) 2024 [PMID: 39793541]

Venezuelan equine encephalitis virus

  1. Barton RD, Tregoning JS, Wang Z, Gonçalves-Carneiro D, Patel R, McKay PF, Shattock RJ. A sort and sequence approach to dissect heterogeneity of response to a self-amplifying RNA vector in a novel human muscle cell line Molecular therapy. Nucleic acids 36(1):102400 2025 [PMID: 39759876]
  2. Casmil IC, Bathula NV, Huang C, Wayne CJ, Cairns ES, Friesen JJ, Soriano SK, Liao S, Ho CH, Kong KYS, Blakney AK. Alphaviral genetic background of self-amplifying RNA enhances protein expression and immunogenicity against SARS-CoV-2 antigen Molecular therapy : the journal of the American Society of Gene Therapy 2024 [PMID: 39741413]
  3. Rangel MV, Sebastian A, Leon NF, Phillips AM, Gorman BM, Hum NR, Weilhammer DR. Single-cell and spatiotemporal transcriptomic profiling of brain immune infiltration following Venezuelan equine encephalitis virus infection Frontiers in immunology 15:1497839 2024 [PMID: 39749347]
  4. Massey SE. The Growing Phenomenon of 'Frozen' Virus Genome Sequences and Their Likely Origin in Research Facility Escapes Microorganisms 12(12) 2024 [PMID: 39770614]

Vibrio cholerae

  1. George CM, Namunesha A, Endres K, Felicien W, Sanvura P, Bisimwa JC, Perin J, Bengehya J, Maheshe G, Cikomola C, Bisimwa L, Mwishingo A, Sack DA, Domman D. Effectiveness of a single dose of oral cholera vaccine: findings from epidemiological and genomic surveillance of Vibrio Cholerae in the Democratic Republic of the Congo (PICHA7 Program) medRxiv : the preprint server for health sciences 2024 [PMID: 39763551]

Yersinia pestis (Plague)

  1. Avril A, Guillier S, Rasetti-Escargueil C. Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies Microorganisms 12(12) 2024 [PMID: 39770824]
  2. Hendrix EK, Sha J, Kilgore PB, Neil BH, Verma AK, Chopra AK. The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice Vaccines 12(12) 2024 [PMID: 39772023]

Click HERE to see the publications in the last month.